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  1A SUMMARY 
1A SUMMARY 
ClpC, a member of the AAA+ protein superfamily from Bacillus subtilis, is forming with 
ClpP a proteolytic system, that is part of the protein quality control system and involved in 
general proteolysis of misfolded and aggregated proteins. In addition ClpCP together with the 
adaptor MecA is necessary for the regulated proteolysis of the transcription factor ComK in 
competence development of B. subtilis. The ClpCP mediated regulatory proteolysis controls 
also stress response and sporulation in B. subtilis. 
In this work the in vitro chaperone activity of ClpC was investigated. It was discovered that 
the presence of the adaptor protein MecA is essential for the chaperone activity of ClpC, 
because it targets substrate to ClpC and activates ClpC by assisting the oligomerisation of 
ClpC. 
In particular MecA enabled ClpC to disaggregate and refold previously heat aggregated 
Luciferase and Malate Dehydrogenase. In the presence of ClpP, MecA enabled the 
subsequent degradation of unfolded or previously heat-aggregated proteins by ClpCP while 
native proteins were not degraded. In addition it was demonstrated that the MecA paralogue 
YpbH, which is not involved in the regulatory proteolysis in B. subtilis, displayed comparable 
chaperone activities. Therefore MecA and YpbH may have a general and complementary 
function in protein quality control. These and other experiments suggested that MecA can 
coordinate substrate targeting with ClpC activation and that the ATPase induction of ClpC by 
MecA was necessary but not sufficient for this activation.  
The question why MecA is necessary for the general activation of ClpC was addressed in 
more detail. It could be demonstrated that in the presence of ATP MecA assists the assembly 
of an active higher oligomer of ClpC via formation of a ClpC-MecA heterodimer. This higher 
oligomeric complex is a prerequisite for all the activities of AAA+ proteins and consists 
presumably of a hexamer of ClpC interacting with up to six MecA molecules. The N-terminal 
and the Linker domain of the first AAA+ domain of ClpC were identified as MecA 
interaction sites and structural determinants necessary for this process. 
Controlling the ability of an AAA+ protein to form an active ring is an important functional 
aspect by which the activity of this protein family can be specifically regulated by an adaptor 
protein.  
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   1B ZUSAMMENFASSUNG 
1B ZUSAMMENFASSUNG 
 
ClpC, ein Protein der AAA+-Superfamilie aus Bacillus subtilis, ist zusammen mit ClpP ein 
Teil der zellulären Protein-Qualitätskontrolle und für die generelle Proteolyse von 
missgefalteten und aggregierten Proteinen zuständig. ClpCP ist außerdem wichtig für die 
gerichtete Degradation von regulatorischen Proteinen, welche die Stressantwort, die 
Sporulation und die Kompetenzentwicklung in B. subtilis kontrollieren. Der genaue 
Mechanismus dieser Regulation konnte für die Kompetenzentwicklung genauer untersucht 
werden. Es konnte gezeigt werden, dass das Adaptorprotein MecA notwendig ist, um 
zusammen mit ClpCP den Transkriptionsfaktor ComK der Kompetenzentwicklung in B. 
subtilis gezielt zu degradieren, und dass MecA gleichzeitig die ATP-Hydrolyse von ClpC 
stimuliert.  
In dieser Arbeit wurden die in vitro Chaperon-Eigenschaften von ClpC untersucht. Es konnte 
gezeigt werden, dass die Anwesenheit des Adaptorproteins MecA essentiell für die ATPase 
und die Chaperon-Aktivität von ClpC ist. 
Diese Arbeit legt dar, dass MecA die Disaggregation und Rückfaltung der hitzeaggregierten 
Modellsubstrate Luciferase und Malatdehydrogenase durch ClpC ermöglicht. Weiterhin 
ermöglicht MecA auch die Degradation von ungefalteten und aggregierten Proteinen durch 
ClpCP. Zusätzlich konnte gezeigt werden, dass das MecA-Paralog YpbH, welches nicht an 
der regulierten Proteolyse in B. subtilis beteiligt ist, mit MecA vergleichbare Chaperon-
Aktivitäten besitzt. Daher können MecA und YpbH generelle und komplementäre Funktionen 
in der Protein-Qualitätskontrolle haben. Diese Experimente schlagen eine durch MecA 
koordinierte Substrat-Erkennung und ClpC-Aktivierung vor, für welche die ATPase-Aktivität 
von ClpC zwar notwendig aber nicht allein ausreichend ist. 
Der Mechanismus der generellen Aktivierung von ClpC durch MecA wurde genauer 
untersucht. Es konnte nachgewiesen werden, dass ClpC ohne Adaptor ein inaktives Monomer 
ist, welches durch Zugabe von MecA über ein Heterodimer in Anwesenheit von ATP zu 
einem aktiven hexameren Komplex oligomerisiert wird. Weitere Experimente zeigten, dass 
für die Interaktion von ClpC mit MecA die N- und die Linker-Domäne notwendig sind. Die 
Kontrolle der Ringbildung und somit der ATPase- und Chaperon-Aktivität von ClpC durch 
ein Adaptorprotein stellt einen neuen Kontrollmechanismus von AAA+-Proteinen dar. 
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   2 INTRODUCTION 
2 INTRODUCTION 
 
2.1 Protein folding in vitro and in vivo 
 
Newly synthesized protein chains must fold into defined three-dimensional structures, to 
become functionally active. All information about the structure of a protein is encoded in its 
aminoacid sequence. Proteins fold within the range of seconds or even milliseconds, although 
the number of theoretical possible but wrong conformations is extraordinary high. The 
mechanism of the protein folding process is currently described by folding funnels of energy 
landscapes (Schultz, 2000). All non-native conformations of a protein possess a higher energy 
and protein folding can be imagined as a ball rolling down the slope of the energy landscape 
into a funnel. The native structure represents the thermodynamically most favored status at 
the bottom of the folding funnel. The folding funnel of a protein represents many different 
folding pathways that can be used by the unfolded protein to reach the energy minimum 
(native structure). This process can be fast or slow, depending on the shape and the gradient 
of the funnel. 
Folding processes inside the cell are much more complex than the refolding of denatured 
model proteins in vitro. Proteins are synthesized in vivo at the ribosomes in a vectorial manner 
from the N to the C terminus (Figure 1). In contrast to in vitro experiments, which are 
performed with diluted (< 1 g/l protein) and complete polypeptide chains, nascent 
polypeptides emerging from the ribosome do not contain the complete information necessary 
for folding. In addition, the concentration of cytosolic macromolecules including ribosomes, 
nucleic acids and proteins, is very high (340 g/l) (Goodsell, 1991).  
In this macromolecular crowded environment exposed hydrophobic amino acids of nascent 
polypeptides and folding intermediates may interact inappropriately leading to protein 
misfolding and aggregation. A number of proteins are also structurally labile and their 
folding status is even more susceptible to changes of the cellular environment. Stress 
conditions, like a sudden increase in temperatures, can therefore lead to unfolding and 
aggregation of many proteins (Figure 1). 
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2.2 The chaperone network 
 
2.2.1 De novo folding 
 
To optimize cellular protein folding, protective systems have developed in the course of 
evolution. These systems consist of families of highly conserved proteins so called molecular 
chaperones. Chaperones are found in high concentrations in all cells, from bacteria to humans. 
They guide a large variety of folding processes throughout the life cycle of proteins from 
synthesis to their degradation (Figure 1). The various chaperones protect non-native protein 
chains from misfolding and aggregation, but apparently do not contribute conformational 
information to the folding process. Chaperones were first identified as stress- or heat-shock 
proteins (HSPs). They assist folding processes at different stages throughout the lifetime of 
proteins, from synthesis to degradation (Figure 1).  
Depending on their function, chaperones can be classified into “holder“ or “folder“ 
chaperones. Holder chaperones (e.g. small HSPs) can prevent the aggregation of misfolded 
protein species independent of ATP without mediating protein reactivation. Folder 
chaperones (e.g. Hsp60/GroEL, Hsp70/DnaK) can support in addition substrate refolding, 
 Figure 1. Chaperone network and
which is ATP dependent. 
 protein quality control system in E.coli. The figure illustrates the function of 
different chaperone and protease systems. Chaperones assist the de novo protein folding (1), the refolding of 
misfolded proteins (3) and/or prevent protein misfolding and aggregation (2). Once proteins are aggregated they 
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can be disaggregated and refolded (4). Alternatively misfolded and aggregated proteins can be degraded by 
proteolytic systems (5). For details see text. 
 
Newly synthesized proteins of bacteria associate with the chaperone trigger factor, as soon as 
 factor the newly synthesized polypeptide chain can 
.2.2 Repair of misfolded proteins 
tress conditions like a sudden increase in temperature, can lead to protein unfolding and 
 GroEL chaperon consists of two stacked rings of seven subunits each. After 
they leave the exit tunnel of the ribosome (see Figure 1 step 1)(Deuerling et al., 1999; Teter et 
al., 1999). Exposed hydrophobic side chains of the newly synthesized polypeptides are most 
likely protected from wrong interactions by association with trigger factor. In addition, trigger 
factor may prevent premature folding until a complete domain has emerged from the 
ribosomal exit site. (Bukau et al., 2000)  
It is assumed that after release of trigger
start or continue its folding to the native state. The kinetics of the folding process and the 
yield of correctly folded proteins differ from protein to protein. Small proteins (< 30 kDa) 
can, in general, fold rapidly and without guidance of chaperones into their native structure 
(~65 to 80% of cytosolic proteins). Larger proteins (10 to 20% of cytosolic proteins) fold 
more slowly and can interact during their folding process either with the GroEL or the DnaK 
chaperone system. DnaK associates with both, nascent polypeptides and polypeptides released 
from the ribosome (see Figure 1 step 1), in contrast to the GroEL machine, which is supposed 
to associate with newly synthesized proteins exclusively after their release from the 
ribosome.(Deuerling et al., 1999; Ewalt et al., 1997; Patzelt et al., 2001; Teter et al., 1999)  
 
2
 
S
aggregation (Figure 1, step 2 + 3). Different chaperone systems function as a protective 
system that prevents protein aggregation by binding to the misfolded proteins, e.g. the DnaK 
(HSP70) and GroEL (HSP60) systems. The DnaK system consisting of DnaK, DnaJ and 
GrpE cooperates in addition with another family of chaperones the small heat shock proteins 
(sHSP`s). These substrates can subsequentlybe refolded by DnaK and/or GroEL(Figure 1 step 
3). DnaK consists of an N-terminal ATPase domain and a C-terminal substrate-binding 
domain. Substrate binding and release is controlled by the nucleotide state and co-chaperones 
DnaJ and GrpE.  
The barrel shaped
ATP binding substrates are enclosed in a “folding chamber” by the association of the GroES 
co-chaperone. 
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The importance of molecular chaperones can be demonstrated by analysing the phenotypes of 
E. coli cells missing a specific chaperone system. For example E. coli cells lacking the HSP70 
chaperone DnaK exhibit a temperature-sensitive growth phenotype (Paek and Walker, 1987) 
and accumulate large amounts of aggregated proteins at high temperatures (Hesterkamp and 
Bukau, 1998). 
 
2.2.3 Refolding of aggregated proteins 
 
During severe stress high substrate load can overburden the cellular chaperone capacity, 
leading to accumulation of protein aggregates. Studies using the model systems bakers yeast 
Saccharomyces cerevisiae, the bacterium E. coli and the plant Arabidopsis thaliana, 
demonstrated that pre-existing protein aggregates can be successfully disaggregated and even 
refolded to the active conformation (Glover and Lindquist, 1998; Hong and Vierling, 2000; 
Lee et al., 1997; Mogk et al., 1999). Protein disaggregation is achieved by a bi-chaperone 
system, consisting of ClpB (Hsp104) and the DnaK (Hsp70) machine (see figure 2 arrow 4). 
Importantly only the combination of both chaperone systems is active in resolubilization and 
refolding of aggregated proteins. This activity of the bi-chaperone system is directly linked to 
the survival of the mentioned organisms at very high temperatures (Hong and Vierling, 2000; 
Sanchez and Lindquist, 1990). Disaggregation of protein aggregates was demonstrated in vivo 
and in vitro using thermolabile malate dehydrogenase (MDH) as a reporter 
enzyme.(Goloubinoff et al., 1999) Large aggregates of MDH can be solubilized in vitro and 
MDH is subsequently refolded into its native structure.  
 
2.3 The AAA+ superfamily 
 
The AAA+ superfamily (ATPase associated with a variety of cellular activities) of ATPases, 
which contain a homologous ATPase module, are found in all kingdoms of living organisms 
where they participate in diverse cellular processes. 
Hsp104/ClpB is a member of the conserved Hsp100/Clp protein family, a group of ring-
forming ATPases (Schirmer et al., 1996). 
Neuwald and colleagues found that Hsp100/Clp proteins and AAA proteins share conserved 
motifs involved in ATP binding and hydrolysis and they combined both protein classes to 
generate a new protein superfamily: the AAA+ proteins (Lupas and Martin, 2002; Neuwald et 
al., 1999). Generally, AAA+ proteins remodel target substrates in an ATP-dependent manner, 
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an activity that is of central importance for a large number of cellular processes (Karata et al., 
2001; Vale, 2000). 
The structural basis of this superfamily was confirmed by determining the structure of various 
AAA+ proteins (Bochtler et al., 2000; Guo et al., 2002; Lenzen et al., 1998; Li and Sha, 2002; 
Yu et al., 1998; Zhang et al., 2000). 
AAA+ proteins share a common ATPase domain with a conserved sequence of 230-250 
amino acid residues referred to as the AAA+ domain. Each AAA+ domain consists of a core 
ATPase domain, containing the classic Walker A and B motifs, and a C-terminal α-helical 
domain (Figure 2). The superfamily can be further divided into two distinct classes, based on 
the number of AAA+ domains present in the protein (Schirmer et al., 1996). Class I proteins 
(e.g. ClpA, ClpB, and ClpC) contain two AAA domains, referred to as AAA-1 and AAA-2, 
separated by a linker sequence of variable length (Fig. 3). In contrast, class II proteins (e.g. 
ClpX and HslU(ClpY)) contain only one AAA domain (homologous to AAA-2).  
Monomer
Hexamer
top view
side view
AAA+ domain
 
Figure 2 Common structural features of AAA+ proteins. The AAA domain consists of a core domain with a 
RecA-like fold (red) and a α-helical subdomain (yellow) The core domain contains the Walker A (GX4GKT) 
and Walker B (HyDE) nucleotide binding motifs, where X= any amino acid and Hy = hydrobphobic amino acids 
(Top left). The structures of an HslU monomer and HslU hexamer are shown.  
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2.3.1 AAA+/HSP100 proteins involved in protein degradation 
 
The removal of non-native proteins by proteolytic systems is another pathway of the protein 
quality control system. A number of AAA+ proteins (e.g. ClpA, ClpX, HslU) associate with 
proteolytic components (ClpP, HslV) to form ATP-dependent proteases. Some AAA+ 
proteins (e.g. Lon) also contain a peptidase domain within a single polypeptide (Fig. 3). 
Proteins of the Hsp100/Clp family are the best-studied proteolytic systems. ClpAP, ClpXP 
and HslUV form barrel-like structures with two heptameric/hexameric rings of ClpP/HslV 
flanked on either side by hexameric rings of ClpX, ClpA or HslU (Beuron et al., 1998; Sousa 
et al., 2000). The active sites of ClpP and HslV are located in a chamber inside the barrel and 
are therefore isolated from the surrounding medium and inaccessible to folded proteins 
(Bochtler et al., 2000; Sousa et al., 2000; Wang et al., 1997). The access of substrates to the 
proteolytic chambers occurs through narrow pores, which are not wide enough to allow 
passage of globular proteins (Wang et al., 1997). Therefore, substrate proteins must be 
unfolded by the AAA+ component and threaded into the protease for degradation. 
Consequently, substrate recognition by the AAA+ components represents the first step in 
protein degradation and must be highly controlled in order to protect cells from uncontrolled 
proteolysis.  
In order to fulfill their function in protein quality control, AAA+ proteins must be able to 
distinguish misfolded from properly folded proteins. In this process, AAA+ proteins compete 
and/or cooperate with other chaperone systems in binding unfolded proteins (Gottesman et al., 
1997). 
AAA+ proteins also play a key role in the removal of truncated polypeptides, which cannot 
reach the native state (Keiler et al., 1996). When protein synthesis is stalled at eubacterial 
ribosomes caused by e.g. truncated mRNAs that are lacking a stop codon a short peptide tag is 
coupled to the protein (Fig.1 step 6). The peptide tag is encoded by a RNA, which has 
properties of both transfer and messenger RNA. This 11-residue peptide (AANDENYALAA), 
the SsrA tag, is added to the C terminus of the incomplete polypeptide and directs the protein 
to specific multisubunit protease complexes, ClpXP or ClpAP. The SsrA-tagging system not 
only permits the dissociation of the truncated polypeptide from the ribosome but also targets 
the unwanted protein for degradation by several proteolytic machines including ClpXP and 
ClpAP (Gottesman et al., 1998).  
Besides degrading misfolded proteins, AAA+ proteins are also involved in regulatory 
proteolysis. Selective removal of regulatory proteins, like transcription factors or signal 
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transduction proteins, is an efficient and fast strategy to control checkpoints for e.g. 
development or cell differentiation (Jenal and Hengge-Aronis, 2003). Unlike misfolded 
substrates, regulatory proteins are properly folded and can possess different destruction tags 
for their recognition by AAA+ proteins. Although the recognition motifs of several regulatory 
substrates (e.g. RepA, MuA and λ O) have been identified, the substrate specificity of ClpX 
has been most extensively studied. Using a proteolytic inactive variant of ClpP Baker and co-
workers were able to trap a large number of ClpX substrates in vivo. From this analysis they 
were able to identify five different degradation signals, located either at the N- or C-termini. 
C-terminal recognition signals were either similar to the SsrA-tag (Leu-Leu-Ala-COOH) or to 
the MuA recognition signal (enrichement of basic residues), while N-terminal degradation 
motifs were more variable (Flynn et al., 2003).  
 
2.3.2 Extra domains of AAA+/HSP100 proteins 
 
In order to carry out their chaperone and regulatory functions AAA+ proteins must exhibit 
diverse substrate specificities. Thereby AAA+ proteins may posses multiple recognition sites 
within a single molecule, some of which may be common to all AAA+ proteins while others 
are unique to individual AAA+ proteins. One possibility to ensure substrate specificity is to 
recognize substrates via extra domains, which are missing in other members of the protein 
superfamily (Figure 3). 
Extra domains are usually encoded N-terminal to the AAA domain, but can also be inserted 
within an AAA domain. They are located at the distal end of the AAA+ oligomer and thereby 
placed in an ideal position to make initial contacts with substrates (Bochtler et al., 2000; Guo 
et al., 2002; Sousa et al., 2000). 
The N-domains of ClpA and ClpB are independently folded domains, which are attached to 
the AAA domain via a flexible linker (Lo et al., 2001; Singh et al., 2001; Tek and Zolkiewski, 
2002) 
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Figure 3 Structural features of prokaryotic AAA+ proteins. The AAA domains, although highly conserved, 
contain significant differences and can be classified accordingly (AAA-1, AAA-2). N-terminal domains of 
AAA+ proteins are diverse and are in most cases involved in substrate recognition, either directly or indirectly 
by serving as a binding platform for adaptor proteins. The AAA domain of HslU is interrupted by the specialized 
I-domain, which is proposed to mediate SulA binding. Similarly a middle domain (M domain) of variable length 
is inserted into the AAA-1 domains of ClpB and ClpC. The middle domain of ClpB has an essential, however 
yet unknown function. Lon also contains an additional proteolytic domain. Adaptors/functional partners and 
identified substrates of the corresponding AAA+ proteins are given. The targeted substrates are indicated by an 
arrow. 
 
The N-domain of ClpX is different to the N-domains of ClpA and ClpB. It forms a stable 
dimer and is complexed with Zn (II) cations via a zinc finger motif (Banecki et al., 2001; 
Wojtyra et al., 2003). ∆N-ClpX is still able to bind SsrA-tagged proteins and to support GFP-
SsrA degradation in vitro and in vivo (Dougan et al., 2003; Singh et al., 2001; Wojtyra et al., 
2003). However, ∆N-ClpX is affected in MuA degradation in vitro and, consistently, ∆N-
ClpX cannot function in disassembling MuA-DNA complexes in vivo (Wojtyra et al., 2003). 
Consistently MuA, but not GFP-SsrA, were recently demonstrated to bind to the isolated N-
domain of ClpX. Thus it appears that ClpX contains at least two different binding sites: one is 
present in the N-domain and is required for binding MuA, while the second resides in the 
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AAA domain and mediates interaction with GFP-SsrA. This demonstrated that an N-domain 
could be involved in specific substrate interaction (Wojtyra et al., 2003). 
The Linker (or middle domain) is proposed to form a coiled coil, which is repeated, two times 
in ClpB and once in ClpC. Its function is poorly studied although as a coiled coil, it is likely 
to play a role in protein-protein interactions, either in protein oligomerisation or perhaps in 
substrate binding. (Dougan et al., 2002a). 
HslU contains a discrete domain (the I-domain), which is inserted between the Walker A and 
B motifs of the AAA domain (Fig. 3). The I-domain appears as a flexible region with coiled 
helices and is located at the distal end of the HslU oligomer (Bochtler et al., 2000; Sousa et 
al., 2000). Deletion of the I-domain does not affect HslU hexamerization or the association 
with the HslV peptidase (Kwon et al., 2003; Song et al., 2000). However, ∆I-HslU did no 
longer prepare SulA, a cell division inhibitor protein, for degradation by HslV. Since 
degradation of casein was not affected in this deletion variant, the I-domain may play a 
specific role in SulA binding (Song et al., 2000). In addition extra loops, which confer the 
interaction of ClpA, ClpX and ClpC with ClpP had been identified (Dougan et al., 2002b). 
 
2.4 AAA+ adaptor proteins 
 
An alternative way to ensure substrate specificity of AAA+ chaperones is the presence of 
adaptor proteins, which assert their effects through specific binding to both, substrates and 
AAA+ partner proteins and deliver specific substrates in a trans-targeting mechanism to the 
AAA+ proteins (Fig. 2) (Dougan et al., 2002a). Currently there is an increasing number of 
adaptor proteins reported not only in bacteria but also in higher organisms. Many adaptor 
proteins modulate the activity of their parent AAA+ chaperone by binding to the N-terminal 
domain (Dougan et al., 2002b; Dougan et al., 2003; Yuan et al., 2001). This mode of binding 
positions the adaptor proteins at the side or on the top of the AAA+ ring, placing them in an 
ideal position to hand over the bound substrates to the AAA+ partner protein. 
 
2.4.1 SspB and RssB 
 
A simple strategy to enlarge the substrate pool of AAA+ proteins is the usage of an individual 
adaptor protein, which is delivering the bound cargo upon binding to its AAA+ partner 
protein, recognizes specific substrates. The first such adaptor protein identified in E. coli for 
ClpX include SspB (stringent starvation protein B) and RssB (Regulator of Sigma S). SspB 
was identified as a specificity factor of ClpX, which enhances the degradation of SsrA-tagged 
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proteins by ClpXP (Levchenko et al., 2000). Tagged polypeptides are directly transferred by 
SspB to ClpXP. SspB is not essential for the degradation of SsrA-tagged substrates by ClpXP, 
but becomes especially important at low substrate concentrations, which are probably 
physiologically relevant (Wah et al., 2002).  
RssB is the second adaptor protein of ClpX and is essential for the degradation of the 
starvation sigma factor σS by ClpXP. Several stresses increase cellular σS levels by inhibiting 
proteolysis of σS, which under non-stress conditions is a highly unstable protein. Proteolysis 
of σS requires the response regulator RssB. RssB can directly interact with σS and can target 
its substrates to ClpXP. The interaction of RssB with σS is dependent on RssB 
phosphorylation and thereby the phosphorylation status of RssB controls σS stability. The in 
vivo signal transduction cascade that leads to RssB phoshorylation is still unknown (Becker et 
al., 1999; Muffler et al., 1996; Pratt and Silhavy, 1996; Zhou et al., 2001). 
 
2.4.2 ClpS 
 
Besides targeting specific substrates, adaptor proteins can also play a different role in 
controlling the activity of AAA+ partner proteins. One adaptor proteins, which did not only 
target specific substrate, is ClpS, a ClpA-specific adaptor protein (Dougan et al., 2002c; Zeth 
et al., 2002b). ClpS modulates ClpA substrate specificity by binding to the N-domain of its 
AAA+ partner protein. (Guo et al., 2002; Zeth et al., 2002a). ClpS was shown to regulate the 
degradation of two different Clap-mediated substrates. Recognition  and consequently 
degradation  of aggregated proteins was enhanced by the presence of ClpS. In contrast, ClpS 
was shown to inhibit both binding and degradation of SsrA-tagged substrates. The mechanism 
of the ClpS-mediated switch of ClpA activity and the modulation of ClpA substrate specifity 
is largely unknown. Since ClpS and SsrA-tagged substrates bind to different regions of ClpA, 
the inhibitory activities of ClpS towards this substrate class cannot be explained by 
competition for the binding to the same site within ClpA. However, ClpS binding can trigger 
the release of pre-bound SsrA-tagged substrates (Dougan et al., 2002c). It was therefore 
proposed that binding of ClpS to the N-domains of ClpA causes conformational changes in 
ClpA, resulting in the shielding and exposure of substrates binding site for SsrA-tagged 
substrates and protein aggregates, respectively (Zeth et al., 2002b). In addition ClpS inhibits 
the autodegradation of ClpA in vitro and in vivo (Dougan et al., 2002c). 
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2.5 AAA+ chaperones of Bacillus subtilis 
 
The gram-positive soil bacterium Bacillus subtilis is next to E. coli the best-studied 
prokaryotic organism. B. subtilis possesses four different Clp ATPases, ClpC, ClpE, ClpX 
and ClpY (Fig. 4). ClpX and ClpY are orthologues of the E. coli ClpX and ClpY proteins. 
The E. coli HSP100 proteins ClpA and ClpB are missing in B. subtilis. ClpC possesses an N-
terminal domain homologous to ClpA and ClpB and a middle domain half the size of the 
ClpB middle domain. ClpC and ClpE are exclusive in B. subtilis and most of the other fully 
sequenced gram-positive organisms. 
The ClpE protein is a prototype of a novel subfamily among the Clp ATPases. It consists of 
two AAA domains, a domain that is inserted into AAA-1 and an N-terminal domain that is 
homologous to the N-domain of ClpX from E. coli and B. subtilis. 
The B. subtilis HSP100 proteins form complexes with subunits (ClpP or HslV), like their E. 
coli counterparts.  
 
 
Figure 4 A comparison of the B. subtilis HSP100/Clp proteins. Class I proteins contain a variable N-terminal (in 
gray) and two AAA domains (AAA-1 and AAA-2) separated by a linker domain of variable length. Class II 
proteins contain only one AAA domain. N-terminal domains with a Zinc binding motif are marked in magenta 
(ClpE and ClpX).  
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2.6 Role of ClpC and the adaptor MecA in regulated and general proteolysis in B. 
subtilis 
 
2.6.1 Regulated proteolysis in B. subtilis 
 
Adaptor proteins are not only found in E. coli. In fact, the first characterized adaptor protein, 
MecA, was discovered in B. subtilis. The adaptor protein MecA of B. subtilis was identified 
together with ClpC in a genetic screen for repressors of competence development (Roggiani 
et al., 1990). During the last years it has been shown that ClpCP is also directly involved in 
the regulation of several cellular processes and as a part of the protein quality control system. 
ClpCP is responsible for the degradation of key regulators, as shown in the following chapters 
for ComK, SpoIIAB, Spx, MurAA and CtsR 
 
2.6.1.1 Competence development 
 
MecA is a negative regulator of competence and acts together with ClpC to target the master 
regulator for competence development (ComK) for proteolysis by ClpCP (Persuh et al., 1999; 
Turgay et al., 1998; Turgay et al., 1997). Signalling through a quorum sensing system results 
in the expression of a small protein ComS, which like ComK, interacts with the N-terminal 
domain of MecA leading to the release and stabilization of ComK. The released ComK 
activates not only its own transcription but also the transcription of all the genes necessary for 
the competent state. Once the signal (ComS) is removed, MecA is able to rebind the highly 
abundant ComK and targets it for degradation by ClpCP until the previously competent cells 
return to a normal physiological state (see Figure 4) (Dubnau, 1999; Dubnau and Turgay, 
2000; Turgay et al., 1998). Interestingly, a homologue of MecA known as YpbH also interacts 
with ClpC. YpbH, however, is not involved in the control of ComK activity (Persuh et al., 
2002). These data suggest that MecA is a specific adaptor protein for competence regulation. 
However homologues of MecA and ClpC are also widespread in other bacterial species, 
which lack ComK homologues. This suggests that the roles of MecA and ClpC are not only 
limited to controlling competence development. 
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Figure 5. The competence switch. The dotted outlines indicate degradation. The circled + symbol indicates that 
ComK operates positively on its own promotor. A, K and S represent MecA, ComK and ComS, respectively 
(Dubnau and Turgay, 2000). 
 
2.6.1.2 The anti-sigma factor SpoIIAB is degraded by ClpCP 
 
Transcriptional regulation in bacteria can be controlled by factors acting to alter promotor 
utilization. The process of transcription begins when RNA polymerase (RNAP) holoenzyme 
(core + σ) binds to a specific promoter region (deHaseth et al., 1998). In B. subtilis, one 
notable class of regulators are the alternative σ-factors that bind to the core enzyme (in place 
of the primary σ-factor) and thereby direct the RNA polymerase to recognize new promoter 
sites (Haldenwang, 1995). Some sigma factors (i.e. sigma B, sigma F, and sigma G) are 
inhibited by "anti-sigma factor" which block their ability to form RNA polymerase 
holoenzymes. The transcription factor σF, which is activated in a cell-specific manner during 
sporulation in B. subtilis, is initially held in an inactive complex by the anti-sigma factor 
SpoIIAB. The anti-anti-sigma factor SpoIIAA interacts with SpoIIAB−σF and induces the 
release of free σF and free SpoIIAB. Free SpoIIAB is subject to proteolysis while it is 
protected from degradation by σF in the SpoIIAB-σF complex and by SpoIIAA in an 
alternative complex. Proteolysis of SpoIIAB requires residues located near the extreme C 
terminus of SpoIIAB and is dependent upon the ClpCP protease (Pan and Losick, 2003). In a 
clpC null mutant SpoIIAB is stabilized and as a consequence these mutants are deficient in 
sporulation. The interaction of SpoIIAA with SpoIIAB-σF and the resulting degradation of 
newly released SpoIIAB could set up a self-reinforcing cycle that locks on the activation of 
σF (Pan et al., 2001). 
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2.6.1.3 ClpC and MecA degrade the transcriptional regulator Spx (YjbD) 
 
The stability of a newly discovered stress dependent transcriptional regulator Spx (YjbD) is 
controlled by ClpXP but can also get degraded by ClpCP in presence of MecA or YpbH. Spx 
is an "anti-α" factor (α-factors interact with the C-terminal domain of the α-subunit of 
RNAP), which blocks transcriptional activation by binding to the α-subunit, thereby 
interfering with the capacity of RNAP to respond to certain activator proteins. It has been 
shown that Spx suppress defects in competence development conferred by clpP and clpX 
mutants. The levels of Spx protein in wild-type cells grown in competence medium are low, 
while those in clpP mutants are high. 
An in vitro proteolysis experiment using purified proteins demonstrated that Spx was 
degraded by ClpCP, but only in the presence of one of the ClpC adapter proteins, MecA or 
YpbH. (Nakano et al., 2003b; Nakano et al., 2002b). The in vivo relevance of this degradation 
is not clear, however Spx was shown to be involved in stress related induction of MecA 
transcription (Nakano et al., 2003a). 
 
 
2.6.1.4 Degradation of MurAA by ClpCP 
 
MurAA which catalyses the first committed step in the peptidoglycan biosynthesis pathway 
has been recently identified as another possible substrate of ClpCP. Peptidoglycan constitutes 
an essential component of the bacterial cell wall, providing mechanical resistance to the 
internal osmotic pressure and determining cell shape. Stabilisation of MurAA was observed in 
∆clpC-mutant strains and the in vivo stability of MurAA depended on the presence of ClpC 
and ClpP. This Clp dependent degradation is especially enhanced upon entry into stationary 
phase. To control growth of B. subtilis the MurAA protein could be a target for regulatory 
proteolysis by ClpCP (Kock et al., 2003).  
 
 
2.6.1.5 Degradation of CtsR 
 
Only parts of the stress response regulation of B. subtilis are understood yet. Based on distinct 
regulatory features five different classes of stress-inducible genes have been defined. The 
transcription of Class III heat shock genes, which encode HSP100/Clp proteins, is controlled 
by the CtsR repressor (class three stress gene repressor). CtsR negatively regulates the 
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expression of clpP, clpE and the clpC operon, by binding to operator sequences in front of 
these operons (Derre et al., 1999a). CtsR is stable during non-stressed conditions, but is 
degraded upon temperature upshift by ClpCP. Thereby, ClpC acts as a positive regulator of 
the heat shock response in B. subtilis The activity of CtsR is controlled by the two modulatory 
proteins, McsA and McsB, whose genes are encoded by the clpC operon (ctsR, mcsA, mcsB 
and clpC). McsA contains zinc finger motifs and interacts with McsB under non-stressed 
conditions. McsB, a putative tyrosine kinase, remove the repressor from the DNA and target 
CtsR for degradation by the ClpCP protease during stress (Krüger et al., 2001).  
 
 
2.6.2 General proteolysis in B. subtilis 
 
ClpC functions as a general stress protein, its expression is heat shock regulated and a clpC 
deletion strain is thermosensitive and less thermotolerant (Krüger et al., 1994; Msadek et al., 
1994). Krüger et al. showed, that the presence of ClpC is also necessary for the general 
protein quality control system in B. subtilis. Turnover rates for abnormal puromycyl peptides 
are significantly decreased in clpC, clpX and clpP mutant cells. This demonstrated that ClpC, 
ClpX and ClpP participate directly in general proteolysis of misfolded proteins. Electron-
dense aggregates, most likely caused by the accumulation of misfolded proteins, were noticed 
in studies of ultrathin cryosections in heat shocked cells and even under non-stressed 
conditions in clpC, clpX and clpP mutant cells. Furthermore clpC, clpX and clpP mutant cells 
are deficient in the ability to solubilize or degrade damaged and aggregated proteins. ClpC 
like ClpX and ClpP also localizes to protein aggregates in heat-shocked cells and to inclusion 
bodies formed by overproduced insoluble heterologous proteins (Jürgen et al., 2001; Krüger 
et al., 2000). Based on these findings it is assumed that ClpCP plays an important role in the 
removal of unfolded and aggregated proteins in B. subtilis. 
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2.7 Aim of this work 
 
To elucidate the chaperone functions and the mechanism of the AAA+ protein ClpC, the role 
of its adaptor protein MecA and other adaptor proteins should be examined.  
 
- MecA, necessary for ClpC chaperone activity 
The chaperone activities of ClpC and MecA in prevention of protein aggregation, protein 
refolding and protein disaggregation should be examined in vitro with the model substrates 
Luciferase and Malate Dehydrogenase (MDH). It will be tested whether MecA is required for 
the ClpCP mediated degradation of model substrates.  
 
- MecA controlled activation of ClpC 
MecA can target proteins to ClpC but is also necessary to activate ClpC. To elucidate the 
molecular mechanism of this additional function of MecA the influence of MecA on the 
oligomerisation of ClpC should be examined. Therefore ClpC and different ClpC variants will 
be analysed by gelfiltration and chemical crosslinking experiments. Additionally the MecA 
induced ATPase of ClpC and different ClpC variants need to be determined.  
 
- MecA-ClpC interaction 
The identification of the ClpC domains necessary for the ClpC-MecA interaction would 
provide further insight into the mechanism of MecA mediated ClpC activation. 
Therefore ClpC, mutated in the Walker motifs of the first and the second AAA+ domain, 
which are able to bind but not hydrolyse ATP will be analysed for MecA interactions and 
MecA mediated activity. In addition deletions of possible MecA binding sites in ClpC, such 
as the N-terminal domain (NTD) and the Linker, should be investigated in this work.  
 
- Other ClpC adaptors 
Recently YpbH has been identified to be a paralog of MecA (Persuh et al., 2002). In 
collaboration with the group of Prof. M.Hecker, J.Kirstein showed that McsB, a modulator of 
CtsR repression, is needed for ClpCP mediated degradation of CtsR. In this work the newly 
identified adaptors will be compared to MecA in ATPase stimulation, disaggregation and 
refolding abilities and oligomerisation of ClpC. 
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3 MATERIAL AND METHODS 
 
3.1 Materials  
 
3.1.1 Equipment  
 
Analytical balance        Mettler AE 100 
Centrifuges   Heraeus, Kendrow, 
Sorvall, Beckmann 
Circulardichroismus-spectrometer     J715 Jasco 
Fluoro/PhosphoImager       FLA3000 FujiFilm 
Fluorescence-/absorptions spectrometer  LS50B, 
PerkinElmer/Applied 
Biosystems 
FPLC + columns        Amersham Biosciences 
Fraction collector       Amersham Biosciences 
French Press         SLM-AMin.co 
Shaker (Gels)         GFL 
Gradient mixer for Polyacrylamidegels self-construction of the 
institute’s workshop 
HPLC + columns  Applied Biosystems 
(BioCad) 
Incubators        Heraeus 
Balance         Mettler PM 2000 
Lumat          LB9501 Berthold 
Minigelapperatus        BioRAD® 
Phosphoimager plates       Raytest 
Power supply        Amersham Bioscience 
Stirrer         Heidolph 
Sonifier         450 Branson 
Spectrometer         UV-1601 Shimadzu 
Static Lightscattering       Wyatt Technology 
Scintillation counter 2500TR Canberra-
Packardt 
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Thermoblock         Eppendorf, Techne 
Vortex         Ikamag 
Waterbath        Bioblock Scientific 
 
3.1.2 Chemicals 
 
Acrylamide       Roth (Karlsruhe, GER) 
Adenosine triphosphate, disodium salt   Sigma-Aldrich (Steinheim, GER) 
Adenosine diphosphate, disodium salt   Sigma-Aldrich (Steinheim, GER) 
Agarose       Roth (Karlsruhe, GER) 
Ammonium peroxodisulfate (APS)    Merck (Darmstadt, GER) 
Ampicillin       Roth (Karlsruhe, GER) 
Bacto agar       Difco Laboratories (Detroit, USA) 
Bacto trypton       Difco Laboratories (Detroit, USA) 
Bacto yeast extract      Difco Laboratories (Detroit, 
USA) Chloramphenicol      Sigma-Aldrich 
(Steinheim, GER) 
Coomassie brilliant blue G-250    Roth (Karlsruhe, GER) 
Ethidium bromide      AppliChem (Darmstadt, GER) 
Glutaraldehyde, 25 % in water    Roth (Karlsruhe, GER) 
Guanidinium hydrochloride     Roth (Karlsruhe, GER) 
Isopropyl-β-D-thiogalactopyranoside   AppliChem (Darmstadt, GER) 
(IPTG) 
β-mercaptoethanol      Roth (Karlsruhe, GER) 
o-nitrophenyl-β-D-galactopyranoside   Sigma-Aldrich (Steinheim, GER) 
Phenyl-methyl-sulfonyl-fluoride (PMSF)   AppliChem(Darmstadt,GER) 
Polyoxyethylene sorbitan-monolaurate   Roth (Karlsruhe, GER) 
(Tween 20) 
Phosphoenolpyuruvate     Sigma-Aldrich (Steinheim, GER) 
Sodium dodecylsulfate (SDS)    Roth (Karlsruhe, GER) 
Tetracycline (tet)      Merck (Darmstadt, GER) 
N, N, N’, N’-Tetramethylethylendiamine   Sigma-Aldrich (Steinheim, GER) 
(TEMED) 
N-succinimidyl-[2,3-3H]propionate     Amersham 
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All other chemicals were analytical grade and obtained from Roth, Sigma or Merck. Only 
High purity solvents were used for Äkta purifier gelfiltration runs. 
 
 
3.1.2 Standards and Kits 
 
3.1.2.1 Protein standard 
 
Premixed Protein Molecular Weight Marker (low range) 
 Roche Diagnostics (1.4, 21.5, 26.6, 39.2, 66.2, 97.4 kDa) 
Prestained SDS Molecular Weight Markers  
Sigma (33.5, 38.5, 56, 69, 87,112, 205 kDa) 
Molecular weight standard  
Biorad (670, 158, 44, 17, 1.35 kDa) 
 
3.1.2.2 Kits 
 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick-Plasmid-Präparation-Kit Qiagen 
QIAquick-Gel-Extraction-Kit Qiagen 
Ni-NTA-Spincolumn Kit Qiagen 
 
3.1.3 Expendable items  
 
Centricon      Amicon 
Chromatography paper,     Whatmann 3MM Vetter, St. Leon-Rot 
Dialysis membrane      Medicell International Ltd. 
Immobilon PTM PVDF-    Membran Millipore 
Membrane filter      Schleicher & Schleicher 
Nitrocellulose Membrane     Roth (Karlsruhe, GER) 
Protein Assay       BioRAD® 
Scintillation vials      Roth (Karlsruhe, GER) 
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3.1.4 Proteins and Enzymes 
 
α-casein (bovine milk)    Sigma-Aldrich (Steinheim, GER) 
bovine serum albumin (BSA)    Sigma-Aldrich (Steinheim, GER) 
Malate dehydrogenase    Roth (Karlsruhe, GER) 
Luciferase      Sigma-Aldrich (Steinheim, GER) 
Pyruvatkinase      Roth (Karlsruhe, GER) 
Lysozyme      Roth (Karlsruhe, GER) 
 
3.1.5 Media and antibiotics 
 
LB broth: 
10 g/l Bacto trypton 
5 g/l   Bacto yeast extract 
5 g/l   NaCl 
15 g/l Bacto agar (only for culture plates) 
 
2xYT: 
16 g/l trypton 
10 g/l yeast extract 
5 g/l NaCl 
 
Special media like SPIZ II are described in the according protocol they are used for. 
 
Antibiotic stock solutions (for E.coli): 
Ampicilline   100 mg/ml in H2O (store at –20°C) 
Chloramphenicol   30 mg/ml in 70% (v/v) ethanol (store at –20°C) 
Kanamycine   30 mg/ml in H2O (store at –20°C) 
Tetracycline   20 mg/ml in 70% (v/v) ethanol  
      (store in the dark at –20°C) 
 
Antibiotic stock solutions (for B.subilis): 
Ampicilline   30 mg/ml in H2O (store at –20°C) 
Chloramphenicol   10 mg/ml in 70% (v/v) ethanol (store at –20°C) 
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Kanamycine   10 mg/ml in H2O (store at –20°C) 
Tetracycline   10 mg/ml in 70% (v/v) ethanol  
 
The antibiotics are added to the media in a dilution of 1:1000 . 
 
3.1.6 Materials for chromatography 
 
- S200 HR10-30 (pharmacia) 
- S300, 120 ml, (pharmacia) /HiPrep 16/60 Sephacryl S-300 HR 
 
 
3.2 Molecular cloning techniques 
 
3.2.1 Bacterial strains and plasmids 
 
Table I 
Strain   Relevant genotype or properties  Source and/or reference 
Escherischia coli  
SG22189  MC4100 ∆clpA clpP::cat malP::lacIQ S.Gottesman 
ER2566  F-λ- fhuA2 [lon] ompT lacZ::T7 gene1 
gal sulA11 ∆(mcrC-mrr)114::IS10 
R(mcr-73::miniTn10-TetS)2  
R(zgb-210::Tn10)(TetS) endA1 [dcm] New England BioLabs 
M15   nalS,strS, rifS, lac, ara, gal, mtl, F-;   
        (Zamenhof and Villarejo, 1972) 
 
Bacillus subtilis  
IS75   his leu metB5     I. Smith 
BD1991  IS75 amyE::comK-lacZ cat   (Hahn et al., 1995) 
clpC-WB1 BD1991 (clpC-E280A)   K. Turgay/ C.Escher 
clpC-WB2 BD1991 (clpC-E618A)   K. Turgay/ C.Escher 
clpC-DWB BD1991 (clpC-E280A/E618A)  K. Turgay/ C.Escher 
clpC-∆Linker BD1991(clpC-∆P412-E471    K. Turgay/ C.Escher 
replaced by two amino acids)  
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plasmid  Relevant genotype or properties  Source and/or reference 
pTYB2  Cloning vector for IMPACT* CN system New England BioLabs 
pClpC   pTYB2 with clpC    (Nakano et al., 2002a) 
pClpC-WB1 pTYB2 with clpC-WB1   K. Turgay/ C.Escher 
pClpC-WB2 pTYB2 with clpC-WB2   K. Turgay/ C.Escher 
pClpC-DWB  pTYB2 with clpC-DWB   K. Turgay/ C.Escher 
pClpC-∆N pTYB2 with clpC-∆N    K. Turgay/ C.Escher 
pClpC-∆Li pTYB2 with clpC-∆Li   K. Turgay/ C.Escher 
pQMA   pQE60 with mecA-His6   (Turgay et al., 1997) 
pQYH   pQE60 with ypbH-His6   K. Turgay  
pNTD   pQE60 with mecA(1-92)-His6   (Persuh et al., 1999) 
pCTD   pQE60 with mecA(87-218)-His6  (Persuh et al., 1999) 
pClpP11  pQE70 with clpP-His6   (Turgay et al., 1998) 
 
(*Intein Mediated Purification with an Affinity Chitin-binding Tag) 
 
The mutations ClpC E280A referred to as ClpC-WB1, ClpC E618A referred to as ClpC-WB2 
and ClpC E280A/E618A referred to as ClpC-DWB, ClpC lacking the N-domain (referred to 
as ClpC-∆N; in which amino acids M2-L141 were removed) or the linker domain (referred to 
as ClpC-∆Li; in which amino acids P412-E471 were replaced by a two amino acid linker) 
were introduced into clpC by standard molecular biological methods including site directed 
mutagenesis, PCR, and fusion PCR. The cloning vector for the IMPACT CN system was used 
for these manipulations and the introduced changes were confirmed by sequencing. ClpC-WT 
protein and all other ClpC constructs were over expressed using the E. coli strain ER2566. 
MecA, YpbH, the C-terminal domain (CTD) of MecA and the N-terminal domain (NTD) of 
MecA were over expressed using the E. coli strain M15. ClpP expression was performed 
using the strain SG22189 (see Table I) 
The respective B. subtilis mutant strains clpC-DWB, clpC-WB, clpC-WB2 and clpC-∆Linker 
were constructed like the respective WT strain BD 2827 on the basis of B. subtilis BD 1991 
and confirmed as described previously (Turgay et al., 2001).  
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3.2.2 Competent cells of E. coli 
 
1 ml overnight culture was added to 100 ml pre-warmed LB medium containing the relevant 
antibiotic(s) in a 500 ml flask and shaken at 37°C until an OD600 of 0.5 is reached 
(approximately 90–120 min). The culture was cooled on ice for 5 min and transferred to a 
sterile, round-bottom centrifuge tube. The cells were harvested by centrifugation at low speed 
(5 min, 4000 x g, 4°C). The supernatant was discarded carefully. The cells were always kept 
on ice. The cells were resuspended gently in cold (4°C) TFB1 buffer (30 ml for a 100 ml 
culture) and the suspension was kept on ice for an additional 90 min. After that the cells were 
centrifuged again (5 min, 4000 x g, 4°C) and the supernatant was discarded carefully. The 
cells were resuspended carefully in 4 ml ice-cold TFB2 buffer and aliquoted into 100–200 µl 
in sterile micro centrifuge tubes and frozen in liquid nitrogen or a dry-ice ethanol mix. The 
competent were stored cells at –70°C. 
 
Buffers: 
TFB1 buffer: 
(sterile filtered)    
100 mM  Rubidiumchloride 
     50 mM  Manganesechloride 
     30 mM  Potassiumacetate 
     10 mM  Calciumchloride 
     15 %(v/v) Glycerine 
       HCl pH 5.8 
TFB2 buffer: 
(Autoclaved)       
10 mM  Mops, pH 8.0 
     10 mM  Rubidium chloride 
     75 mM  Calciumchloride 
     15 %(v/v) Glycerine 
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3.2.3 Isolation of plasmid DNA from E. coli  
 
 
3.2.3.1 Purification Protocol 
 
Plasmid DNA purification was performed by using Qiagen “QIAprep Spin Miniprep Kit” 
centrifugation columns that uses the highly specific binding of DNA to a silica gel membrane 
matrix. DNA extraction was performed as described, according to the procedure suggested in 
the supplemented Qiagen handbook (QIAprep Miniprep Handbook, Qiagen 1999). 
This protocol is for Mini (up to 20 µg) preparations of high-copy plasmid DNA from cultures 
of E. coli. Bacterial cells from a 6 ml overnight culture were harvested by quick 
centrifugation (13,000 rpm 1 min, at RT), resuspended in 250 µl resuspension buffer (buffer 
P1), and opened by alkaline lysis adding 250 µl buffer P2. The addition of 300 µl 
neutralization buffer (buffer N3) caused precipitation of cell debris, cellular proteins and 
chromosomal DNA, which were subsequently removed by centrifugation (13,000 rpm 10 
min, at RT). The supernatant containing the dissolved plasmid DNA was applied directly onto 
the Qiagen silica gel spin columns provided and centrifuged (13,000 rpm 1 min, at RT) to rid 
it from other soluble cellular components. The bound DNA was washed twice using 750 µl 
PE buffer (13,000 rpm 1 min, at RT), spun dry (13,000 rpm 1 min, at RT) and eluted in 30 µl 
EB buffer (13,000 rpm 1 min, at RT). 
 
Buffers: 
P1 (suspension) 
     50 mM Tris/HCl pH 8.0 
     10 mM EDTA 
     100 µg/ml Rnase A 
P2 (cell lysis) 
     200 mM sodium hydroxide 
     1 %(v/v) SDS 
N3 (neutralisation) 
     2.55 M potassium acetate 
PE (wash) 
     1 M sodium chloride 
     50 mM MOPS pH 7.0 
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     15 % (v/v) ethanol 
EB (buffer) 
     10 mM Tris/HCl, pH 8.5 
 
3.2.4 Cleavage of DNA with restriction endonucleases 
 
For restriction analysis, typically 1µg of plasmid DNA was mixed with 5-10 units of the 
restriction enzyme. The volume of the restriction enzyme stock solution (50 % w/v glycerol) 
should not exceed 1/10 of the reaction mixture. The restriction assay was incubated for 1-3 
hours at the temperature optimum of the enzyme. The cleavage products are analyzed by 
agarose gel electrophoresis. 
 
 
3.2.5 Gel electrophoresis of DNA  
 
Agarose gel electrophoresis (1 % w/v) is applied to separate double-stranded DNA molecules 
according to their molecular weight after enzymatic restriction. Agarose is dissolved in TB 
buffer by heating in a microwave oven. After the solution is cooled to < 50°C, it is mixed with 
ethidium bromide (final concentration 0.1 µg/ml). The samples (10-20µl) are mixed with 1/10 
of their volume with agarose gel sample buffer and subjected to electrophoresis for 45 min at 
110 V. The running buffer is TB buffer. After electrophoresis, the intercalated ethidium 
bromide is detected at 302 nm. 
 
 
Buffers: 
TB: 
     90 mM Tris-base 
     90 mM Boric acid 
 
 
Agarose gel sample buffer: 
     0.25 % (w/v) bromphenol blue 
     0.25 % (w/v) xylene-cyanol 
     15 % (w/v) Ficol-400 
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3.3 Biochemical techniques 
 
3.3.1 Preparation of ClpC-intein fusion proteins 
 
A ClpC-WT–intein (or ClpC-DWB-, ClpC-WB1-, ClpC-WB2-, ClpC-∆N- ClpC-∆Li-intein) 
construct in pTYB2 (New England Biolabs) was used for expression, and the ClpC was 
purified as described below. This IMPACT-system (NEB) is a novel protein purification 
system, which utilizes the inducible self-cleavage activity of a protein splicing element 
(named intein) to separate the target protein from the affinity tag. It distinguishes itself from 
all other purification systems by its ability to purify, in a single chromatographic step, a native 
recombinant protein without the use of a protease. A target protein is fused to a tag consisting 
of the intein and the chitin-binding domain, which allows affinity purification of the fusion 
precursor on a chitin column. In the presence of thiols such as DTT, β- mercaptoethanol or 
cysteine, the intein undergoes specific self-cleavage, which releases the target protein from 
the chitin-bound intein tag resulting in a single-column purification of the target protein. 
 
 
3.3.1.1 Growth of bacteria 
 
A culture (1500 mL 2xYT with Amp, 37°C, in 5l flasks) was inoculated from cells grown 
overnight of E. coli (ER2566 from Biolabs bearing the plasmid pClpC). The culture was 
grown to an OD600 of ∼ 0.6. At this optical density 0.5 mM (final concentration) isopropyl-ß,-
D-thiogalactoside (IPTG) was added. The flasks were then placed into a precooled incubator-
shaker at 15°C and shaken over night at this temperature. The cells were harvested by 
centrifugation (4500 rpm, 4°C, 15 min, Sorvall F7S rotor), resuspended in cell-lysisbuffer 
with the smallest possible volume. Finally, the pellets were frozen and stored at –20°C. 
 
 
3.3.1.1.1 Purification of ClpC 
The solubilised pellets were thawn and lysed in a French Pressure cell (1200 PSI). The extract 
was centrifuged (18000 rpm, 4°C, 45 min in an SS34 rotor). The soluble fraction was mixed 
with 1 ml of Chitin beads (previously washed with water and equilibrated with the column 
buffer) per 1500 ml culture. When the cell extract was viscous, it was necessary to add a 
small amount of DNAse I (Roche). This mixture was than incubated over night in an 
 36
   3 MATERIAL AND METHODS 
overhead shaker. The next day the beads were poured into a column (biorad 20 ml) and the 
flowthrough was collected for SDS-gel analysis. The column was washed with 10-20 CV 
(Column volumes) with column buffer. In addition, the first and the last ml of this washing 
procedure were collected for SDS-gel analysis. Subsequently two CV of cleavage buffer were 
added separately to the column and collected for SDS-gel analysis. All this, starting with the 
celllysis was done in the cold-room and/or on ice. The column with the cleavage buffer was 
kept over night in the cold room for the self-splicing reaction. The next day (about 16 h later) 
the protein was eluted with the elution buffer and collected. All samples were prepared with 
the 3x SDS-PAGE Sample buffer and analysed by SDS-gel, withe subsequent coomassie 
stain. The fractions containing the protein were pooled and dialysed. 
 
Buffers: 
Column & Elution Buffer: 
500 mM NaCl 
20 mM Tris-HCl pH 8.0 
1mM EDTA 
Cell Lysis Buffer: 
500 mM NaCl 
20 mM Tris-HCl pH 8.0 
1 mM EDTA 
0,1% Triton X 100 
+ complete (Proteinase inhibitors from Boehringer, 1 Tablet/50 ml) 
 
 
Cleavage Buffer: 
500 mM NaCl 
50 mM DTT 
20 mM Tris-HCl pH 8.0 
1 mM EDTA 
Dialysisbuffer: 
200 mM KCl 
33 mM Bicin pH 8.9 
5 mM MgCl2 
1 mM DTT 
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3x SDS-PAGE Sample buffer: 
187.5 mM Tris-HCl pH 6.8 
6% SDS 
30% Glycerol 
0.03% Bromphenol Blue 
 
3.3.1.1.2 Second purification step of ClpC 
The next step of the ClpC purification always was an anion exchange with a ResourceQ 1ml 
(Amersham Pharmacia). For unknown reasons only active ClpC- molecules bind to this 
column. The pooled and dialysed fraction from the Chitin column was then diluted with an 
equal volume of buffer A and loaded on a resource Q. The ClpC was eluted with a linear 
gradient (0-1000 mM KCL) of buffer A and buffer B. ClpC and the ClpC mutant proteins 
eluted at 180 mM KCl.  
A final protein concentration of 1- 3 mg/ml was obtained using this standard purification. The 
protein was aliquoted and frozen in liquid nitrogen and stored at –80°C. 
 
 
Buffers: 
Buffer A: 
50 mM Bicin pH 8.9 
5mM MgCl2 
1mM DTT 
125 µM EDTA 
 
 
Buffer B: 
1M KCl 
50 mM Bicin pH 8.9 
5mM MgCl2 
1mM DTT 
125 µM EDTA 
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3.3.2 Preparation of His-tag fusion proteins 
 
3.3.2.1 Growth of bacteria 
 
Cells of the E.coli strain M15 (for ClpP SG22189) containing the expression plasmid pQMA 
were grown over night at 37°C in a sterile tube containing 2xYT and ampicillin (100µg/ml). 
Then a 2l flask containing 1l of 2xYT and ampicillin (100µg/ml) was inoculated with the cell 
culture. The flask was shaken moderately. At an OD600 of 0.6 IPTG was added to a final 
concentration of 0.5 mM and the cells were grown an additional 4 hours. Then the cells were 
harvested by centrifugation (4500 rpm, 4°C, 15 min), dissolved in buffer A containing 
protease inhibitors (from Boehringer, 1 Tablet/50 ml) and lysed in a French Press cell (as 
described above). The extract was centrifuged (18000 rpm, 4°C, 45 min) the soluble fraction 
was diluted into 50 ml and applied onto a nickel-nitrilotriacetic acid (NTA) agarose column (2 
ml equilibrated with bufferA on a FPLC System (Pharmacia)). The column was washed with 
buffer A and then with buffer A containing 40 mM imidazol and the protein was then eluted 
with a gradient of 40-250 mM imidazol in buffer A. The fractions with the highest 
concentrations of proteins (judged by SDS-PAGE) were pooled and dialysed. {Irgendwo 
sagen welche Proteine so gereinigt werden, vielleicht hier}For concentration and as a final 
purification step of MecA and YpbH an anion exchange column run (resource Q) was 
performed as described for the ClpC purification. In this case, buffer A and B were adjusted 
to a pH of 8.5. The protein was aliquoted and stored at –80°C.  
 
 
3.3.3 Other Proteins 
 
Purifications of DnaK, DnaJ, GrpE and ClpB, were performed according to published 
procedures (Goloubinoff et al., 1999). Protein concentrations were determined using the Bio-
Rad Bradford assay with BSA as a standard.  
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3.4 Gel electrophoresis and protein detection 
 
3.4.1 Gel electrophoresis of proteins 
 
The discontinuous sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed according to Laemmli (Laemmli, 1970). 
The following solutions were used for the preparation of 15% polyacrylamide mini gels (11 
cm x 7 cm x 0,1 cm) 
 
 
Separating gel (20 ml):   
10 ml 30% acrylamide-bisacrylamide (37:1) 
    5 ml 1.5 M Tris/HCl pH 8.8 
    5 ml ddH2O 
    200 µl 10% (w/v) SDS 
    40 µl TEMED  
(N, N, N’, N’-tetramethylethylendiamine) 
    100 µl 10% (w/v) APS (ammonium peroxodisulfate) 
Stacking gel (10ml):   
1,5 ml 30% acrylamide-bisacrylamide (37:1) 
    2,5 ml 0.5 M Tris/HCl pH 6.8  
    5,5 ml ddH2O 
    100 µl 10% (w/v) SDS 
    30 µl TEMED 
    30 µl 10% (w/v) APS 
Running buffer:   
50 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS 
Sample buffer (4x)   
40 % glycerol 
    500 mM Tris/HCl pH 6.8 
    8 % (w/v) SDS 
    0.6% (w/v) bromphenol blue 
    20 % (v/v) β-mercaptoethanol 
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Protein samples were mixed with 1/3 of their volume with sample buffer and heated for 5 min 
at 95°C. 
The mini gel runs were performed at a electric current of 20 mA per gel for the stacking gel 
and 40 mA for the separating gel. 
Large protein gels (12 cm x 28 cm x 0,2 cm) were run at a constant voltage of 150 V for the 
stacking gel and at max. 250V for the separating gel. 
If the runs of large protein gels were performed during the night, the used voltage should not 
exceed 40V. Standard proteins for SDS-PAGE were from Roche Diagnostics. 
The gels were stained with Coomassie solution or with silver staining.  
 
 
3.4.2 Coomassie staining 
 
The gel was carefully removed from the glass plates after the electrophoresis was completed 
and transferred to a petri dish for staining. The gel was completely covered with staining 
solution, warmed shortly in the microwave for one minute at a low voltage and incubated for 
twenty more minutes while shaking on a shaking plate. Once the gel was evenly stained, it 
was washed briefly with water before transferring it to the destaining solution.  
 
Staining solution: 
     25% (v/v) Ethanol 
     10% (v/v) acetic acid 
     0.25% (w/v) Coomassie brilliant blue R250 
     60% (v/v) ddH2O 
 
Destaining solution: 
     20% (v/v) Ethanol 
     10% (v/v) acetic acid 
     70% (v/v) ddH2O 
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3.4.3 Silver stain 
 
Silver staining is a much more sensitive method to detect proteins. Typically less than 10 ng 
of protein can be detected with silver staining, whereas an about 50 times higher amount of 
protein is needed to be detectable by Coomassie staining. 
The SDS-gel must be incubated in the fixing solution over night or a minimum of 60 min. 
Then the gel has to be washed two times with water and treated with Na2S2O3 solution for one 
minute. The staining occurs for 20 minutes in the AgNO3-solution. Then the gel has to be 
washed again 4-6 times with double distilled water. As a next step the gel is developed in the 
Na2CO3 solution. When the bands become visible the buffer has to be exchanged with stop 
solution. 
 
Buffers: 
Fix solution:     
500 ml Ethanol (prep. Grade) 
     400 ml ddH2O 
     100 ml acetic acid 
     0.5 ml formaldehyde (37%) 
Wash solution:    
500 ml ddH2O 
     500 ml Ethanol (prep. Grade) 
Pretreatment solution:    
0.1 g Na2S2O3x5H2O 
     500 ml ddH2O 
Stainer: solution     
0.4 g AgNO3 (Fluka) 
     0.15 ml Formaldehyd (37%) 
     200 ml ddH2O 
 
Developer solution:    
30 g Na2CO3 (Fluka) 
     0.5 ml Formaldehyd (37%) 
     2 mg Na2S2O3x5H2O 
     500 ml ddH2O 
Stop solution:      
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220 ml ddH2O 
     220 ml Ethanol (prep. Grade) 
     60 ml acetic acid 
 
 
3.4.4 Immunological methods 
 
3.4.4.1 Production of antisera: 
 
A rabbit was immunized with 0.5 mg of pure MecA, YpbH or ClpC diluted 1:1 in complete 
Freund’s adjuvans. A subsequent booster injection was given after six weeks with 0.5 mg 
pure MecA (YpbH) diluted 1:1 into incomplete Freund’s adjuvans. 30 ml of blood were 
harvested two weeks after the boost and then incubated at 37°C for one hour. The resulting 
clot of blood is incubated for five hours at 4°C. The solution was spun at 4500 rpm for 15 min 
at 4°C (Sorvall, SS34). The Serum was stored at –20°C. 
 
3.4.4.2 Immunoblotting: 
 
Western blot analyses were performed in order to histochemically identify a protein of 
interest from a complex protein mixture that has previously been separated by its molecular 
weight by SDS-PAGE and transferred to a membrane {!!!}. Two different antibodies are 
required, the first (primary) antibody interacting directly with the proteins, which was raised 
against (MecA, YpbH, ClpC), followed by the application of a secondary antibody detecting 
the first antibodies at their constant regions of the immunoglobulins’ heavy chains (FC). 
The protein-samples were subjected to electrophoresis in 15% SDS-polyacrylamide gels. 
Dilutions for the antisera were as follows: MecA, YpbH 1:20000, ClpC 1:10000, McsB 
1:10000. 
Before usage the PVDF membrane has to be washed with Methanol p.a. for 5 min. Then the 
membrane and six sheets of Whatman paper were incubated in blotting buffer for 5 min.  
After that all components were assembled as follows: 
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Cathode 
+
-  3 layers of Whatman paper  
  SDS gel 
  PVDF membrane 
  3 layers of Whatman paper 
Anode 
 
The gel was blotted onto the PVDF membrane with 1.5 mA/cm (45 min). After that the PVDF 
membrane was incubated in blocking solution for 1h at room temperature with gentle shaking 
or over night at 4°C. Next, the PVDF membrane was washed with fresh TBS-T buffer (3 x 10 
min). The primary antibody was diluted in TBS-T (add a small amount of acetone powder to 
inhibit unspecific reactions) and after that the blot was incubated with the diluted primary 
antibody for 1h at room temperature with gentle shaking. Next, the blot was washed in 100-
150 ml of TBS-T: (3x 10´). Meanwhile the fluorochrome-conjugated secondary antibody was 
diluted into TBS-T (1:10000). The blot was incubated with the diluted secondary antibody for 
1 h at room temperature with gentle shaking. Following the blot was washed again in 100-150 
ml of TBS-T: (3x 10´) and the procedure continued with chemifluorescence substrate 
incubation.  
 
Buffers: 
Blotting Buffer (pH 9.2): 
48 mM Tris/HCl pH 9.2  
     39 mM Glycin 
     1.3 mM SDS 
     20% (v/v) Methanol 
 
TBS-T Buffer (pH 7.6):  
20 mM Tris/HCl pH 7.6  
     137 mM sodium chloride 
     0.1 % Tween 20 
TBS Buffer (pH 7.6):    
20 mM Tris/HCl pH 7.6 
     137 mM sodium chloride 
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Blocking solution:    
TBS-T buffer containing 3% (w/v) nonfat-dry milk 
ECF-solution:     
ECF Western Bloting Kit (Amersham Pharmacia) 
 
 
3.4.4.3 Imaging: 
 
The secondary antibodies are covalently linked to an alkaline phosphatase that is used for 
detection purposes. It reacts with ECF solution releasing a fluorophore that can be detected by 
its emission of light at 540-560 nm upon the stimulation with light at a wavelength of 473 nm. 
The washed blot was placed (protein-side up) onto a cleaned surface (e.g. cleaned glass plate). 
Next the membrane was completely covered with ECF (5µL/cm2) solution.. Then the blot was 
covered with a foil for avoiding any air bubbles between foil and blot. After that the blot was 
incubated at room temperature for 5 to 10 min. 
The incubation time for optimal sensitivity depends on the target concentration and should be 
experimentally determined for each new Western blot application. 
Blots can be air dried in the dark before imaging. The blot was positioned, protein-side down, 
onto a clean glass plate.  
The optimal instrumental settings for the fluoroimager FLA-3000 have to be determined 
experimentally. The detected fluorescence is quantified using the MacBAS software (Fuji 
Film). 
 
 
3.5 In vitro Activity Assays 
 
3.5.1 ATPase assay 
 
The ATPase assay was performed according to procedures described by Liberek et al. 
(Liberek et al., 1991). This approach takes into account that ATP can be separated by thin 
layer chromatographically from ADP. The ATP provided carries a 32P-labelled phosphate 
residue at the α position, which allows to monitor and determine the relative  amounts of ATP 
as well as ADP, using ATP hydrolysis rates under steady-state conditions were determined by 
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incubating 400 nM ClpC (wild type and variants) in ATPase buffer containing 2 mM ATP 
and [α-32P] ATP (0.1 µCi, Amersham) at 30°C. 
Hydrolysis of [α-32P] ATP was monitored after separation of ATP and ADP by thin layer 
chromatography in chromatography buffer. The amount of radioactive ATP or ADP was 
quantitated on a phosphoimager (FLA3000, Fuji) by using the MACBAS version 2.5 (Fuji). 
Rates of ATP hydrolysis were determined by using the programme GRAFIT version 3.0 
(Erithacus software). The resulting specific ATPase rates are given as molecules ATP 
hydrolyzed per second per molecule of the HSP100/Clp protein. 
 
Buffers: 
ATPase (MDH-refolding) buffer: 
     100 mM Tris/HCl pH 7.5 
     150 mM KCl 
     20 mM Mg(OAc)2 
     1mM DTT 
 
Chromatography buffer: 
     400 mM LiCl 
     10% (v/v) acetic acid 
 
 
3.5.2 Prevention of aggregation and refolding of heat denatured Luciferase 
 
Luciferase was diluted to a final concentration of 100 nM in refolding buffer containing 
additional 4 mM ATP supplemented with various chaperones (ClpC 0.6 µM, MecA 0.6 µM or 
KJE (DnaK 1 µM, DnaJ 0.2 µM, GrpE 0.1 µM)) in refolding buffer. The reaction mixture 
was incubated for 15 minutes at 43°C. After this, either KJE or the buffer was added and 
luciferase activity was determined at different time points by diluting 1 µl of the reaction 
mixture into 124 µl of assay buffer. After addition of 100 µl of D-luciferin (Sigma) (44 µM 
final concentration), light emission at 560 nm was measured over a period of 5s in a Berthold 
Lumat 9501. To determine the prevention of aggregation properties of Luciferase, Luciferase 
(100 nM) was heat-denatured in the presence of chaperones (ClpC 0.6 µM, MecA 0.6 µM, 
DnaJ 0.6 µM in refolding buffer with ATP regeneration mix (50 µl)) for 15 minutes at 43°C. 
After this, the total luciferase activity was determined as described above. The remaining 
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reaction mixture (30 µl) of each experiment was centrifuged at 16.000 g for 20 min at 4°C. 
The supernatant was carefully removed and the pellet was resuspended in the appropriate 
amount of refolding buffer (max. 50 µl). Pellet and supernatant were analyzed by SDS-PAGE 
followed by a Western-blot analysis with anti-Luciferase antibodies and subsequently 
quantified using the computer program MacBAS.  
 
 
Buffers: 
Refolding buffer: 
     25 mM HEPES/KOH pH 7.6 
     5 mM MgCl2 
     50 mM KCl 
     2 mM ATP 
Assay Buffer: 
     25 mM glycylglycine 
     5 mM ATP 
     15 mM MgSO4 
 
 
3.5.3 Luciferase disaggregation and refolding  
 
The Luciferase (200 nM) was heat denatured in the absence of chaperones for 15 minutes at 
43°C, after which the Luciferase was diluted 1:1 with the reaction mixture containing the 
chaperones (ClpC 0.6 µM, MecA 1.8 µM ClpB 0.4 µM, KJE (DnaK 1 µM, DnaJ 0.2 µM, 
GrpE 0.1 µM)) and 2 mM ATP in a regeneration mixture. The Luciferase activity was 
determined as described above. 
 
 
3.5.4 MDH disaggregation and refolding  
 
MDH (2 µM) was denatured at 47°C for 30 min in MDH-refolding buffer and diluted to a 
final concentration of 0.72 µM in the presence of chaperones (ClpC 0.72 µM, MecA 0.72 µM, 
ClpB 0.72 µM, KJE (DnaK 1µM, DnaJ 0.2 µM, GrpE 0.1 µM)) and 2 mM ATP in the 
presence of an ATP-regenerating system. MDH disaggregation was determined by monitoring 
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light scattering. MDH (2 µM) was denatured at 47°C for 30 min in MDH-folding buffer and 
diluted to a final concentration of 0.72 µM in the presence or absence of indicated chaperones 
(ClpC 0.72 µM, MecA 0.72 µM or 0.24 µM, ClpB 0.72 µM, KJE (DnaK 1µM, DnaJ 0.2 µM, 
GrpE 0.1 µM)). The reaction mixture was incubated for two minutes at 30°C. The 
disaggregation/refolding reaction was started by adding 2mM ATP together with an ATP-
regenerating system. Right angle light scattering was determined in a thermostat-controlled 
cuvette (30°C) at 550nm excitation and emission wavelength in a Perkin Elmer LS50B 
spectrofluorometer. The activity of MDH was measured at 30°C in assay buffer. The time-
dependent oxidation of NADH by MDH was monitored at 340 nm in a Shimadzu UV-1601 
spectrophotometer. Diluting the reaction mixture 1:70 into the assay buffer started the 
reaction: L-malate + NAD+ ? oxaloacetic acid + NADH + H+.  
 
 
Buffers: 
ATP regenerating system: 
     2mM ATP 
     4mM phosphoenol pyruvate 
     20 ng/ml pyruvate kinase 
MDH-refolding buffer: 
     100 mM Tris/HCl pH 7.5 
     150 mM KCl 
     20 mM Mg(OAc)2 
     1mM DTT 
 
MDH assay Buffer: 
     150 mM potassium phosphate buffer, pH 7.6 
     1 mM DTT 
     0.5 mM oxaloacetate 
     0.28 mM NADH (Sigma) 
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3.5.5 Interaction of chaperones with MDH aggregates 
 
MDH (2 µM) was denatured in MDH-refolding buffer as described above and diluted to a 
final concentration of 0.72 µM supplemented with the chaperones (ClpC and MecA in 
different combinations with aggregated or native MDH molecules) at the same concentration. 
After the addition of 4.5 mM ATP in the presence of a ATP-regenerating system the reaction 
mixture was incubated at room temperature for 5 min and subsequently centrifuged at 16000 
g for 30 min at 4 °C. The supernatant and the pellet fractions were analyzed by  SDS-PAGE 
with subsequent Coomassie-stain. 
 
 
3.5.6 MDH/α-Casein degradation 
 
MDH (4 µM) was denatured at 47 °C for 30 min in MDH-folding buffer and then diluted to a 
final concentration of 1.44 µM, which contained the reaction mix supplemented with ClpC, 
ClpP and MecA (all 0.88 µM). To start the reaction ATP (5 mM) with the ATP-regenerating 
system was added to the chaperone-mixture. The reaction was stopped at different time points 
by mixing an aliquot of the reaction mixture with SDS-sample-buffer (on ice). α-Casein (5.8 
µM) degradation was also performed in the MDH-refolding Buffer with the same 
concentration of chaperones. 
 
 
3.5.7 Analytical Size Exclusion Chromatography 
 
Size-Exclusion Chromatography uses porous particles to separate molecules of different sizes. 
It is generally used to separate biological molecules and to determine molecular weights and 
molecular weight distributions of polymers. Molecules that are smaller than the pore size can 
enter the particles and therefore have a longer path and longer transits time than larger 
molecules that cannot enter the particles. All molecules larger than the pore size are 
unretained and elute together. Molecules that can enter the pores will have an average 
residence time in the particles that depends on the molecules size and shape. Different 
molecules therefore have different total transit times through the column. 
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BufferA: 
     100 mM Tris/HCl pH 7,5 
     150 mM KCl 
     20 mM MgAc2 
     1mM DTT 
     5% Glycerin 
 
A S200 HR10-30 (Amersham) column, connected to a Pharmacia ÄKTA FPLC apparatus, 
was equilibrated with buffer A and 50 µl of ClpC (6µM) or the ClpC mutant proteins ClpC-
DWB (6µM), ClpC-Wb1 (6µM), ClpC-Wb2 (6µM), ClpC-∆N (6µM), ClpC-∆Li (6µM) was 
injected. In separate experiments, MecA (6µM/1µM) or the CTD of MecA (6µM) was 
applied to the column in different combinations with the ClpC-WT or Walker B mutants with 
or without 3H-α-Casein (3µM/1µM). The molecular weights were calculated using a 
calibration curve, which was previously determined by running a set of protein standards 
(Biorad 670 kDa, 158 kDa, 44 kDa, 17 kDa, 1.35 kDa) 
The proteins have been diluted to their final concentration and have been incubated in the 
presence or absence of 2mM ATP for 10 minutes. Chromatographic steps were performed 
with a flow rate of 1.0 ml/min at RT.  
Fractions of 0.3 ml have been collected and concentrated by Methanol precipitation (this was 
done by: adding 3x Methanol, centrifugation for 10 min, discarding the supernatant, drying 
pellets in a spin vac and taking it up with 40 µl 1x SDS Sample Buffer, 95°C for 5 min.). 
These samples were further analysed by silver stain or western blot analysis. 
 
 
3.5.8 3H labeling of α-casein 
 
α-Casein were labeled with N-succinimidyl-[2,3-3H]propionate (Amersham) as described 
previously (Gamer et al., 1996), except that free N-succinimidyl-[2,3-3H]propionate was 
removed by dialysis against gelfiltration buffer A  
Tritium labelled α-casein was used to follow substrate interaction of α-casein with the 
ClpC/MecA chaperone system. 3H-α-Casein (3µM/1µM)  (77000cpm/25666cpm) was 
incubated with the proteins as described above and applied to the S200 column. The fractions 
(0.3ml) were collected into scintillation vials and mixed with scintillation-coverfluid (Packard 
Ultima Gold). Radioactivity of the samples was detected by the radioimager (FLA 3000) 
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BufferA: 
     100 mM Tris/HCl pH 7,5 
     150 mM KCl 
     20 mM MgAc2 
     1mM DTT 
     5% Glycerin 
 
 
3.5.9 Cross-linking Assays 
 
All ClpC variants were diluted into the cross-linking buffer (MDH assay buffer) to a final 
concentration of 1 µM. ClpC was incubated at 30 °C in the presence or absence of nucleotides 
(2 mM ATP or ADP) and MecA (1µM) for 10 min. The cross-linking reactions were started 
by adding of 0.1% glutaraldehyde and stopped within 10 min. Reactions were stopped upon 
addition of Sample Buffer. Cross-linking products were separated by a gradient SDS-PAGE 
(4–15%) followed by silver staining. 
 
Buffers: 
Cross-linking Buffer: 
     100 mM Tris/HCl pH 7.5 
     150mM KCl 
     20mM Mg(OAc)2 
     1 mM DTT 
Sample buffer (4x)    
40 % glycerol 
     500 mM Tris/HCl (pH 6.8) 
     8 % (w/v) SDS 
     0.6% (w/v) bromphenol blue 
     20 % (v/v) β-mercaptoethanol 
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3.5.10 BIAcore analysis 
 
Real-time bio molecular interaction analysis (BIA) uses SPR (surface plasmon resonance) to 
monitor bio molecular interactions. One protein is immobilized on the ligand sensor surface 
(e.g. with a nickel bound His-tag) and solution containing the other protein is passed over the 
sensor surface. As molecules from the solution bind to the immobilized protein, changes in 
the refractive index are registered (Schuck, 1997). In all of the SPR experiments described in 
this study only qualitative conclusions were drawn. This is because large amounts of protein 
were immobilized on the chip surfaces which makes it likely that mass transport limitations 
and rebinding artefacts would obscure any quantitative kinetic analysis (Schuck, 1997) 
These assays were performed with a BIAcore 2000 machine. All Buffers and solutions were 
filtered (0,22 µm) and degassed. The amount of the CTD of MecA being anchored on the 
surface of a Ni-NTA-chip was adjusted so that about 800 resonance units of each protein were 
bound. ClpC (200 nM) was passed over the sensor in Eluent buffer. ATP was added as 
described in the text. 
 
 
Buffers: 
Eluent buffer: 
0.01 M HEPES 
0.15 M NaCl  
50µM EDTA  
0.005% Surfactant P20, pH 7.4  
Nickel-solution: 
500µM NiCl4 in eluent buffer. 
 
Regeneration solution:  
0.01 M HEPES, 
0.15 M NaCl, 
0.35 M EDTA, 
0.005 % Surfactant P20, pH 8.3 
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3.5.11 Circular dichroism spectroscopy 
 
Circular dichroism (CD) is very sensitive method to determine the secondary structure of 
polypeptides and proteins. Circular dichroism spectroscopy is a form of light absorption 
spectroscopy that measures the difference in absorbance of right- and left circularly polarized 
light (rather than the commonly used absorbance of isotropic light). The differential 
absorption of radiation polarized in two directions as function of frequency is called 
dichroism. When applied to plane polarized light, this is called linear dichroism; for circularly 
polarized light, circular dichroism. Ellipticity is the unit of circular dichroism and is defined 
as the tangent of the ratio of the minor to major elliptical axis. It has been demonstrated that 
CD spectra between 260 and approximately 180 nm can be used to analyze the different 
secondary structures of a proteins such as: alpha helices, parallel and antiparallel beta sheets, 
turns and others. Like the other forms of absorption spectroscopy (UV/Vis, IR, etc.), CD is 
particularly powerful in monitoring conformational changes. In the region of 230-178 nm, one 
expects to observe effects of backbone conformational changes while CD effects at longer 
wavelengths (>230 nm) should isolate aromatic chromophore contributions and being 
environment dependent should reflect more global, three-dimensional properties of the 
protein. 
Measuring Circular dichroism: 
Far-UV circular dichroism (CD) spectra were recorded in a Jasco J715 spectropolarimeter at 
protein concentrations of 5µM in phosphate puffer (NaxHyPO4) using 0,2 cm cuvettes. 
The residue ellipticity [Θ] MRW (degrees x cm2 x dmol-1) was calculated from the measured 
Θ (in degrees) by using following equation: 
 
 
   [Θ]MRW = Θ x MRW x 0,1 
            d x c 
 
Θ  = measured ellipticity 
MRW  = mean residue weight 
d  = path length in cm 
c  = protein concentration in mg/ml 
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3.6 In vivo activity assays 
 
3.6.1 Gel filtration of cell extracts 
 
Cells (clpC-WT/ clpC-DWB/ clpC-∆Linker) were grown in 200 ml 2YT Medium (inoculated 
from an overnight-culture with Kanamycin) at 37°C up to an OD600 ≈ 0,6-0,7. 100 ml of the 
culture were pelleted for the analysis of the logarithmic growth phase. The other half was 
treated with a heat shock (54°C for 30 min) and then spun down at 4500 rpm 15 min (Heraeus 
multifuge 3 S-R). The Pellets were resuspended in 0.6 ml STM buffer and washed once again 
in the same buffer. 20 µl Lysozyme were added and incubated for half an hour at 37°C to 
obtain protoplasts. Cells were centrifuged again at 10000 rpm at 4°C for 10 min. The 
supernatant (cell wall fraction) and the pellet was collected and then washed again in STM 
buffer. To lyses the cells the pellet was resuspended in 0.5 ml TM buffer and 10 µl DNaseI 
(1mg/ml, 0.15 M NaCl, 50 % glycerol) and 5 µl PMSF (0.1M in ETOH) were added. After an 
incubation of 10 min. on ice the cells were sonificated 5 times (5cycles at 50 % with the 
Sonifier (Branson)), then left on ice for 3 min. This procedure was repeated three times. 
The protein concentration of the cell extracts was determined by using the Bio-Rad Bradford 
assay with BSA as a standard protein.  
The same amount of proteins from each strain was loaded onto a size exclusion column 
(S300, 120 ml, pharmacia). The GF-runs were performed at 0.5 ml/min in the gelfiltration 
buffer. The fractions (1.5 ml) of interest were precipitated, using the TCA precipitation 
protocol (described below).  The already prepared samples were separated with SDS-PAGE 
and were further analyzed by western blotting using antibodies against ClpC and MecA. 
 
Buffers: 
STM: 
     50 mM NaCl 
     25% Sucrose 
     50 mM Tris/HCl pH 8.0 
     5 mM MgCl2 
 
TM: 
     50 mM Tris/HCl pH 8.0 
     5 mM MgCl2 
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Gelfiltration Buffer: 
200 mM KCl 
50 mM Tris/HCl pH 8.0 
5 mM MgCl2 
5% Glycerol 
0.5 mM DTT 
 
3.5.9.1 TCA precipitation 
 
The samples (1 ml of the GF-run fractions) were mixed with 100µl Na+desoxycholat and 
100µl TCA-solution. The samples were then incubated on ice for 20 min and centrifuged for 
15 min at 13000 rpm. Afterwards the supernatants were discarded and the pellets were 
resuspended in ice-cold acetone. The suspension was centrifuged again for 5 min at 13000 
rpm. The acetone was removed by vacuum and the pellets were dissolved in 1x protein 
sample buffer. To adjust the pH a few µl of a 1M Tricine solution were added until the colour 
of the samples switched back to blue. 
 
Buffer: 
72% TCA 
0,15M Na+desoxycholat 
ice cold acetone (-20°C) 
 
3.6.2 Thermal resistance 
 
Thermal resistance of the strains of interest were determined by spot tests as well as following 
growth curves after heat shock. 
 
3.6.2.1 Spot-tests 
 
Spot tests were performed using overnight cultures grown in LB medium. The cultures were 
diluted to the same OD600 (=1). Aliquots from these dilutions were further diluted from 10-1 to 
10-6 in 2YT medium. 10 µL of the dilutions 10-3, 10-4, 10-5 and 10-6 were spotted onto LB 
plates. Plates were incubated at the indicated temperatures for 24 h. 
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3.6.2.2 Growth curves 
 
Overnight cultures of the strains to be tested were diluted into 2YT-medium with Kanamycin 
(20 µl/ml) and incubated again at 37°C for 2h in a shaker. The cultures were diluted to the 
same OD600 (=1). 1ml of this dilution was used to inoculate 50 ml of fresh 2YT-medium 
without an antibiotic. Growth was followed by the measurement of the optical density in a 
spectrophotometer. A heat shock was given by moving the cultures to a 54°C water bath, after 
an optical density of each strain of OD600 (=0.6). At each time point 1 ml of cells was 
removed, and prepared for Western blot analysis as described in chapter 3.6.1 
 
 
3.6.3 β-Galactosidase determinations 
 
Cells were grown in competence medium (SS-II-medium) and extracts, buffers and ONPG 
solutions were prepared as described previously (Albano et al., 1987). The Activity was 
measured in microtitre plates with a Rainbow Shell microplate reader (Tecan). The extract 
(100 µl) was mixed with 400µl assay buffer, and the reactions were started upon addition of 
200 µl of ONPG. 100µl were pipetted into a well of a 96-well-plate and the absorbance at 420 
and 550 nm was measured 
The frozen stocks were spread out onto TBAB-plates for growth over night at 30°C. The cells 
were resuspended in Spiz II medium, grown again to the early log Phase and used to inoculate 
a 50 mL Culture of spizII-medium. The time points were taken close enough to determine t0. 
From each time point three different samples of 1 ml were taken and pelleted at 13000 rpm 
for 10 min. The pellets were resupended in 0.5 ml Assay buffer. 100 µl of the samples were 
diluted with 400 µl assay buffer, 10µl Toluol were added and the samples were vortexed for 
15 sec. and stored at room temperature for 30 min. 
200 µL ONPG (4mg/ml disolved in assay buffer) were added subsequentially to each sample. 
Then the sample was vortexed and the incubation time for each sample was noted. When a 
yellow colour developed the reaction was stopped with 0.5 mL Na2CO3 (1M). 
The cells were pelleted again in a tabletop centrifuge for 5 min at 13000 rpm. 100 µl were 
pipetted into a 96 well plate and the absorbance at 420nm and at 550 nm were determined 
The β-Galactosidase activity was calculated as followed: 
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Miller units = 
 
 
OD420, OD550 = absorption (at 420 and 550 nm) of the sample after the reaction  
OD600 = optical density of the culture before it is pelleted for the β- Galactosidase assay 
t = reaction time 
v = volume of the culture used for the assay 
 
 
Buffers: 
SS-II-Medium:  
     44 mM KH2PO4 anh. 
     80 mM K2HPO4 anh. 
     15 mM (NH4)2SO4 
     0.7 mM Na citrate x 2H2O 
 
Added to 500 ml   1x SS: 
     5 ml 50% glucose 
     5 ml 2% casein hydrolysate 
     5 ml 10% yeast extract 
     2.5 ml histidine 10 mg/mL 
     2.5 ml leucine 10 mg/mL 
     2.5 ml methionin 10 mg/mL 
     5 ml CaCl2 0.05 M 
     12.5 ml MgCl2 0.1M 
Assay buffer:     
0.1 M NaxHyPO4  pH 7.0 
     (to get pH 7.0 mix 0.5 M Stock of NaH2PO4 ≈ 400ml 
     and 0,5 M Stock of Na2HPO4 ≈ 850 ml) 
     0.001 M MgSO4 
     0.001 M KCl 
     0,1 M β-Mercaptoethanol (add just before use) 
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4 RESULTS 
 
4.1 Chaperone activity of ClpC 
 
4.1.1 Chaperone assays using Luciferase and Malate Dehydrogenase 
 
A first step to understand the role of ClpC in protein quality control was to test the activity of 
ClpC and its adaptor protein MecA in several in vitro chaperone assays. These assays include 
the ability to prevent aggregation, refold denatured proteins or disaggregate previously 
aggregated proteins. Chaperone activities are tested in vitro with well-characterized protein 
substrates, like Luciferase (Schröder et al., 1993) from the North American Firefly (Photinus 
Pyralis) or Malate Dehydrogenase (MDH) (Goloubinoff et al., 1999) from pig heart. 
The activity of refolded Luciferase, a monomeric 61-kDa enzyme, can be monitored by the 
activation of D-luciferin. Measuring the bioluminescence of D-luciferin (in Light Units LU) 
monitors the refolding of chemically denatured Luciferase or disaggregation with subsequent 
refolding after heat denaturing.  
Thermally denatured MDH is another well-characterized chaperone substrate, which can be 
used to study the effects of chaperones on protein aggregates (Goloubinoff et al., 1999). Heat 
treatment at 47°C results in the irreversible loss of more than 99% of MDH activity in 30 min. 
After an initial delay of 5–8 min, the light scattering (turbidity) of the solution increased 
rapidly as a consequence of formation of large aggregates. The turbidity and residual 
enzymatic activity remained constant after a temperature downshift to 25°C for at least 5 
hours, demonstrating that heat-inactivated MDH forms stable and irreversible aggregates. 
Under a phase-contrast microscope, aggregated MDH (2 µM) appeared as loose, reticulated 5- 
to 50-µm-long filaments. Gel filtration and SDS-gel electrophoresis of sedimentation-soluble 
and insoluble fractions (4 min at 14,000 g) showed less than 3% of soluble inactive monomers 
in the heat-treated MDH sample. In the absence of chaperones, less than 3% of the MDH 
activity was spontaneously recovered during 24 hours at 25°C (Goloubinoff et al., 1999). 
To follow the chaperone dependent disaggregation of MDH, turbidity was measured in a 
spectrofluorometer. The light scattering decrease in direct correlation to the decrease of MDH 
aggregates. Malate Dehydrogenase (MDH) catalyzes the following enzymatic reaction:  
L-malate + NAD+ ? oxaloacetic acid + NADH + H+.  
This enzymatic activity can be followed by the decrease in absorbance at 340 nm resulting 
from the oxidation of NADH. The rate of the decrease in absorbance is used to measure the 
refolding of MDH (in % of the total activity per second). 
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4.1.1.1 Luciferase 
 
4.1.1.1.1 Interaction of ClpC and MecA with Luciferase aggregates 
 
In order to test the ability of ClpC and MecA to prevent Luciferase aggregation during heat 
shock, Luciferase was heat denatured 15 minutes at 43°C together with MecA, ClpC, and 
ClpC with MecA. As a positive control the holder chaperone DnaJ was added. Bovine serum 
albumin (BSA) was used as a control for unspecific protein-protein interactions. 
After five minutes incubation at 30°C, the amount of soluble or aggregated Luciferase was 
determined by centrifugation of the sample. In addition to that, the Luciferase activity was 
measured to determine the total activity after the heat treatment. This allowed the comparison 
of the total Luciferase activity with the relative amount of soluble Luciferase. 
The resulting supernatant and pellet fractions were analyzed by SDS-PAGE with subsequent 
Western blot (Fig. 1). The determination of the amount of soluble Luciferase, from multiple 
experiments represented in Fig. 1, demonstrated that ClpC, together with MecA, was able to 
maintain 40-50% of the Luciferase in the soluble fraction. Interestingly, 30-40% of Luciferase 
remained soluble in the presence of MecA or ClpC alone.  
 
 
 
 
 
 
 
 
 
 
 
Fig.1) Luciferase was heat denatured 15’ at 43°C together with MecA (in different molar ratios), ClpC, BSA, 
DnaJ or ClpC & MecA (in a 1:1 ratio to each other). Subsequently aliquots were centrifuged. The western-blot 
with anti-Luciferase antibodies of the resulting supernatant and pellet fraction is depicted. The concomitantly 
measured total luciferase activities before the centrifugation for the different experiments are shown in the graph 
below the western-blot.  
 
60-70% of Luciferase remained in the soluble fraction in presence of DnaJ while in contrast 
only 10% remained soluble in the presence of BSA. The Luciferase activity of these samples 
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revealed that although either MecA or ClpC were able to partially maintain Luciferase in a 
soluble state, only when both proteins were present significantly higher activity could be 
rescued. Furthermore, as a control, BSA or DnaJ rescued almost no activity, although 
luciferase solubility was greatest in the presence of DnaJ (Fig. 1).  
The result from this experiment suggested, that ClpC together with MecA exhibited some, 
albeit weak, ability to prevent Luciferase aggregation, and that this level is comparable to that 
of MecA or ClpC alone. The slightly higher prevention of aggregation ability of ClpC 
together with MecA (40-50%) compared to MecA or ClpC alone (30-40%) could result from 
an additive effect of the two components. The level of Luciferase activity after 5 minutes, 
rescued by ClpC and MecA indicates that MecA together with ClpC could have 
disaggregation and refolding abilities.  
 
 
4.1.1.1.2 Prevention of aggregation and reactivation of Luciferase 
 
To examine prevention of aggregation with additional disaggregation and refolding activities 
of ClpC and MecA, the activity of heat-denatured Luciferase was followed with time. 
The Luciferase was heat denatured in the presence of ClpC or MecA, ClpC and MecA and as 
a control with KJE. The Luciferase activity was determined at the indicated time points after 
the samples were returned to 30°C. 
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Fig. 2) Prevention of aggregation and refolding assays with heat aggregated luciferase. Luciferase was heat 
denatured 15’ at 43°C with ClpC, MecA, ClpC and MecA or KJE. Subsequently luciferase activity was 
determined at the indicated time points. 
 
Only ClpC together with MecA could slowly recover Luciferase activity up to 20%, after 3h. 
The initial Luciferase activity was below 5% in the presence of ClpC or MecA, as shown in 
the first experiment and none of these proteins alone could recover Luciferase activity with 
time. The high initial luciferase activity (25%) in the presence of the KJE system reflects the 
prevention of aggregation abilities of this chaperone system. The addition of KJE during heat 
denaturation resulted in the recovery of approximately 80% Luciferase activity. 
The result from these experiments demonstrated, that the ClpC/MecA system was not 
efficient in preventing aggregation compared to KJE, but was able to rescue activity after heat 
treatment. This activity can also be tested by Luciferase refolding experiments. An 
experimental setup to elucidate Luciferase-refolding activity was therefore used 
 
 
4.1.1.1.3 Refolding of chemically denatured Luciferase 
 
In this assay Luciferase was denatured with 6M-guanidinium-hydrochloride and subsequently 
diluted into refolding buffer. Under these conditions Luciferase molecules are unstructured 
and tend to aggregate with time if no chaperone is present. This experimental system can be 
utilized to examine prevention of aggregation and refolding activities. In the experiment 
shown in Fig. 3 the chaperones were added immediately after denaturation, to ensure that 
aggregation can be prevented (holding activity) and refolding starts directly. 
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Fig. 3) Refolding of guanidinium hydrochloride denatured luciferase with ClpC, MecA, ClpC and MecA or KJE 
as shown in the legend. Luciferase activity was determined at the indicated time points. 
 
This experiment demonstrated, that the ClpC/MecA system was not as efficient as the KJE-
system in Luciferase refolding, although the percentage of rescued Luciferase was slightly 
higher in comparison to the activity of ClpC/MecA in the previous experiment. The KJE-
system was able to rescue 100% of the Luciferase to the native state. ClpC alone regained 10 
% of Luciferase activity. MecA was not able to recover Luciferase activity, in comparison 
with the control of denatured Luciferase without chaperones. 
In summary ClpC together with MecA can refold denatured Luciferase, but at a low level 
compared to the KJE system. These results favor the testable hypothesis that ClpC together 
with MecA may act to disaggregate and assist subsequent refolding, instead of preventing 
aggregation and assisting refolding of Luciferase.  
 
 
4.1.1.2 MDH 
 
4.1.1.2.1 Physical association with MDH aggregates 
 
To dissect further the possible chaperone activities of MecA and/or ClpC, the influence of 
ClpC and MecA on preformed protein aggregates were examined. Heat aggregated MDH was 
used as a model system, because it is known to form large protein aggregates. These 
aggregates can be centrifuged to separate aggregated MDH from native proteins. 
First the physical association of ClpC and MecA with aggregated proteins was tested with a 
supernatant pellet experiment. Heat aggregated MDH and native MDH were incubated with 
the various chaperones for 5 minutes. The pelletable fraction was separated from the soluble 
fraction by centrifugation. Only in the presence of ATP, ClpC and MecA could be recovered 
in the pellet fraction (Fig. 4). In the absence of ATP, the recovery of MecA and ClpC in the 
pellet was greatly reduced. If MecA was omitted, then ClpC did not associate with the 
aggregated MDH. If ClpC was absent no association of MecA with the aggregate was visible. 
This indicated, that in presence of ATP a tertiary complex consisting of ClpC and MecA 
interacting with protein aggregates could form. Such a tertiary complex has been previously 
observed for ClpC, MecA and ComK (Turgay et al., 1997). Native MDH was always 
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recovered in the supernatant fraction and heat denatured MDH was always localized to the 
pellet fraction in the absence of chaperones (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4) ClpC together with MecA and ATP associates with aggregated protein. Heat aggregated MDH was 
incubated for 5 min at room temperature with ClpC in the presence or absence of MecA with or without ATP 
(with pyruvate kinase (PK) and phosphoenolpyruvate as ATP regenerating system), as indicated below the gel. 
In addition a control without aggregated MDH (agg. MDH) is shown. A subsequent centrifugation for 30' at 
16000 g separated supernatant and pellet fractions. Supernatant (S) and pellet (P) fractions were analyzed by 
Coomassie-stained SDS PAGE. Positions of the different proteins on the gel are marked. Denatured MDH is 
located in the pellet fraction and native MDH is always recovered in the supernatant. 
 
 
4.1.1.2.2 MDH disaggregation activity 
 
Next, the ability of ClpC and MecA to disaggregate MDH aggregates was investigated.  
MDH was denatured at 47°C for 30 minutes. MDH disaggregation was monitored by the 
changes in light scattering after addition of the respective chaperones. 
The results of these experiments demonstrate that only ClpC together with MecA was able to 
disaggregate MDH aggregates at rates, comparable to the ClpB/KJE system (Fig. 5). Neither 
MecA nor ClpC alone could disaggregate these MDH aggregates. The heat aggregated MDH 
molecules scatters light over 60 minutes without a significant decrease of the signal. 
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Fig. 5) ClpC together with MecA could disaggregate heat aggregated MDH. Previously heat aggregated MDH 
was incubated with the indicated proteins. The disaggregation reaction was subsequently followed in time by 
light scattering measurements. In addition curve fits of the data points are shown. 
 
After it was shown that ClpC/MecA bind and disaggregates MDH aggregates, it remained to 
be elucidated whether ClpC/MecA can also subsequently refold the disaggregated MDH 
molecules. 
 
 
4.1.2 Disaggregation and refolding activity of ClpC and MecA 
 
To determine the fate of the disaggregated MDH, MDH activity was followed upon addition 
of the chaperones. The enzyme activity of MDH can be determined by the decrease in 
absorbance at 340 nm resulting from the oxidation of NADH (see chaperone assays). 
The results of this experiment are depicted in Fig. 6. Only ClpC together with MecA was able 
to disaggregate and refold heat aggregated MDH, comparable to the ClpB/KJE control (Fig. 
6A).  
Interestingly the ClpC and MecA mediated disaggregation of MDH was observed in the first 
30 minutes (Fig.5). Whereas a significant increase of the activity of refolded MDH started 
always after half an hour.  
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Neither ClpC nor MecA alone was able to recover MDH activity from the protein aggregates. 
To ensure that these results were not specific for heat aggregated MDH the disaggregation 
and refolding of heat aggregated Luciferase was also monitored (Fig. 6B). Just like 
aggregated MDH, only ClpC together with MecA could rescue Luciferase activity from the 
aggregated state. 
After 120 minutes the percentage of Luciferase rescued by ClpB/KJE was just 10 % higher 
than the percentage rescued by ClpC/MecA. As a control the chaperone system KJE was 
added without ClpB. 
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Fig. 6A) ClpC together with MecA can disaggregate and refold previously heat aggregated MDH  
Previously heat aggregated MDH was incubated with the indicated proteins and MDH activity was determined. 
6B) ClpC together with MecA can disaggregate and refold previously heat-aggregated Luciferase  
 
Previously heat aggregated luciferase was incubated with the indicated proteins and 
Luciferase activity was determined at the indicated time points. 
These experiments suggested that ClpC, together with the adaptor protein MecA, forms a 
chaperone system, which binds in presence of ATP to protein aggregates and is able to 
disaggregate and refold these aggregated proteins. 
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4.2 ClpCP mediated degradation 
 
Previously it was shown that ClpCP degrades ComK and ComS, but only in the presence of 
MecA. Interestingly, MecA itself was also degraded by ClpCP in vivo and in vitro, but much 
slower than the presented substrates (Turgay et al., 1998). 
The preceding experiments demonstrated, that ClpC together with MecA was able to 
disaggregate and refold substrates like MDH and Luciferase. Therefore it was interesting to 
test whether ClpCP in the presence of MecA is able to degrade misfolded and aggregated 
proteins. α-Casein which is a mostly unstructured protein (Herskovits, 1966) was used as 
substrate representing an unfolded protein. As implicated by the name of the Clp-proteins 
(casein lysing proteins) α-casein was one of the first identified substrates of this protein class. 
 
 
4.2.1 Casein is a substrate for the ClpCP/MecA system 
 
To test the MecA-dependent degradation of α-casein by ClpCP (Fig 7), α-casein was 
incubated with ClpC and ClpP together with MecA. In the presence of MecA, α-casein was 
rapidly degraded following which MecA itself was degraded (Fig. 7C). If the amount of 
MecA was reduced to 0,1µM the band of MecA was not visible anymore after 30 min. while 
α-casein degradation was still observable (Fig. 7D) 
As a control the degradation of MecA without α-casein and the degradation of α-casein 
without MecA was also tested (Fig. 7A+B). MecA as a natural substrate for ClpCP targeted 
itself and was degraded very rapidly. Degradation of α-casein by ClpCP in the absence of 
MecA was not detectable (Fig. 7B). These results demonstrated that the presence of MecA is 
essential for the efficient ClpCP-mediated degradation of α-casein. 
The MecA degradation was slowed down in the presence of α-casein, as it was previously 
demonstrated for the substrates ComK or ComS. 
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                                a                             b                               c                           d 
 
Fig. 7) Degradation of α-Casein by ClpCP depends on the presence of MecA a) MecA itself is degraded within 
15 min. b) α-Casein is not a substrate for ClpCP c) α-Casein is degraded by ClpCP and MecA d) A minimal 
amount of MecA is sufficient to degrade α-Casein. ClpCP with ATP and PK/PEP regenerating system was 
incubated with α-casein with or without MecA (as indicated above). Samples were taken at indicated time points 
and analyzed by coomassie-stained-SDS-PAGE. Sizes of the molecular weight standard (MWS) were depicted 
on the left and the proteins were marked on the right side of the gel. 
 
 
4.2.2 Aggregated MDH can be degraded by the ClpCP/MecA system 
 
To test degradation of heat denatured and thereby aggregated MDH, ClpC, ClpP and MecA 
were incubated with previous aggregated MDH and native MDH. The degradation assay was 
started by the addition of 2mM ATP. The experiment demonstrated (Fig. 8) that after an hour 
up to 50% of the aggregated MDH was degraded. Native MDH was stable in the presence of 
ClpCP, MecA and ATP. In addition the ClpCP mediated degradation of aggregated MDH was 
depending on the presence of both MecA and ATP (Fig. 8). 
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Fig. 8) Previously heat aggregated MDH (1µM) was degraded by ClpCP (1+1µM) only when MecA (1µM) is 
present. Heat aggregated (agg. MDH) or native MDH was incubated with ClpCP with the indicated components. 
Samples were taken at indicated time points and analyzed by coomassie stained SDS-PAGE. The gels were 
scanned and the relative amount of MDH was determined by image analysis and plotted.  
 
However the degradation of aggregated MDH was much slower and less efficient compared 
to the degradation of α-casein (Fig. 8). A concurrent degradation of MecA could explain the 
lower rate. To test the MecA dependency of MDH degradation the amount of MecA was 
titrated in this assay (data not shown). 2µM MecA was needed for the complete degradation 
of the aggregated MDH within 60 minutes. With only 0,5 µM MecA the degradation of the 
aggregates stopped at 70% of the total MDH amount. 
α-Casein degradation continued even at a very low MecA (0.1 µM) concentration (Fig. 7d). 
In contrast only in the presence of a twofold overshoot of MecA (2µM), MDH could get 
degraded almost completely.  
These experiments demonstrate that aggregated MDH is a substrate for MecA mediated 
degradation by ClpCP, whereas native MDH molecules are not degraded. In contrast to α-
casein degradation more MecA was needed for MDH degradation activity. Heat aggregated 
MDH is forming big aggregates, and α-casein is an unstructured protein, that does not form 
aggregates. An explanation for this difference could be a different recognition of these 
different kinds of substrates.  
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4.3 The ATPase activity of ClpC is necessary but not sufficient for chaperone activity 
 
In order to further determine the mechanism by which MecA activates ClpC, the MecA 
dependent ATPase stimulation of ClpC was determined (Table 1 and Fig. 11). The basal ATP 
hydrolysis rate of ClpC was 0.004 s-1. MecA itself has no ATPase activity and it stimulates 
the ClpC rate up to a 360 fold (1,5 s-1) in a ratio of one ClpC to six MecA molecules. In the 
standard disaggregation and refolding assays a ratio of ClpC to MecA of 1:1 was used. This 
molecular ratio induces the ATP hydrolysis of ClpC up to 270 fold (1.1 s-1). The substrates 
used in the assays before (α-casein, luciferase and MDH) were also tested for ClpC ATPase 
stimulation. These substrates did not stimulate the ATPase rate of ClpC (see Table 1). In 
combination with MecA, neither α-casein nor luciferase or MDH stimulated the MecA 
induced ATPase rate as it was shown for the natural substrates of ClpCP/MecA ComK and 
ComS (Turgay et al., 1997). This was also tested with different ratios of MecA to ClpC (data 
not shown).  
The basal rate of ClpC was compared with the basal rates of ClpA (0.54 s-1) and ClpB (0.02 s-
1). The basal ClpC-ATPase rate was about a hundred fold lower than the basal rate of ClpA. 
The addition of MecA to ClpC induced the ATPase activity of ClpC to a level similar and 
higher compared to the ClpA basal rate (Table 1).  
These experiments were consistent with the hypothesis that MecA is needed for ClpC 
function, because it induces the ATPase and thereby the general activity of ClpC. 
 
 
Protein ATPase fold stimulation comment 
ClpC -0.0041 s-1  basal rate 
ClpC + MecA (1:1) -1.108 s-1 270x  
ClpC+ MecA (1:6) -1.475 s-1 360x  
ClpC + Casein -0.007 s-1 2x  
ClpC + den. Luci -0.0041 s-1 no stimulation  
ClpC + den. MdH -0.0041 s-1 no stimulation  
ClpA -0.54 s-1  131x ClpC basal 
ClpB -0.015 s-1  3.6x ClpC basal 
ClpC +CtD (1:1) 0.42  100x Stimulation as with 
 full length MecA 
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(As much as MecA in 
the same experiment) 
(Persuh et al 1999) 
ClpC + NtD -0.0041 s-1 no stimulation  
 
Table 1: ATPase stimulation of different ClpC substrates and a comparison with the ATPase rate of the 
homologue Clp protein of E.coli. The ATPase rate is given in hydrolysis of an ATP molecule per second per 
ClpC molecule (s-1) 
 
 
Previous experiments demonstrated that MecA consists of two domains connected by a 
flexible loop. The N-terminal domain interacts with ComK and ComS, while the C-terminal 
domain interacts with ClpC and is responsible for the induction of the ClpC ATPase reaction 
(Persuh et al., 1999) These fragments of MecA were tested for the stimulation of the ClpC 
ATPase and whether they are sufficient to activate the disaggregation and refolding capacity 
of ClpC. The experiments were carried out with luciferase and MDH as aggregated protein 
substrates. Neither the addition of the N-terminal, or the C-terminal domain of MecA, nor the 
simultaneous addition of both domains (data not shown) to ClpC, resulted in detectable 
disaggregation and refolding activity (Fig.10). 
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Fig 10) disaggregation and refolding activities of the C-terminal and the N-terminal domain of MecA with the 
substrates Luciferase (A) and MDH (B). 
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Nevertheless the C-terminal MecA domain by itself induced the ClpC ATPase to the same 
extent as full length MecA (Table 1). Consistently, addition of the C-terminal MecA domain 
alone was unable to mediate degradation of α-casein or aggregated MDH by ClpCP (data not 
shown and Figure 10 B). The result of these experiments suggested, that the induction of the 
ClpC ATPase is not sufficient for the disaggregation and refolding activity of ClpC together 
with MecA or the degradation by ClpCP.  
To get more insight into the correlation of the ATPase and the disaggregation and refolding 
activity, we followed both the ClpC ATPase rates and MDH refolding rates at several 
different ratios of MecA/ClpC (Fig. 14). A clear correlation between the MecA concentration 
and the yields and rates of refolding and ClpC ATPase rates was apparent (Fig.11 and data 
not shown). With increasing amounts of MecA up to a protomer ratio of 1:1 (MecA: ClpC) 
both the ATPase rate and the refolding rate correlated (Fig. 11). 
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Fig. 11) Comparison of the MDH refolding rate with the ATPase rate MDH refolding rates (left y-axis) and 
specific ATPase rates (right y-axis) were determined as described at different ratios of MecA to ClpC monomers 
(depicted on x-axis) and plotted as indicated in the legend. 
 
Above the 1:1 ratio, the disaggregation and refolding reaction of ClpC/MecA was inhibited, 
while the ClpC ATPase rate continued to increase. Since MecA also acts as a substrate for 
ClpC this could represent a competitive inhibition by MecA. Similar experiments with heat-
aggregated luciferase instead of MDH gave essentially the same results (data not shown). 
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These results suggest that the concomitant targeting of substrate by MecA together with the 
ATPase induction of ClpC is necessary for the disaggregation and refolding activity of ClpC 
with MecA. 
 
 
4.4 YpbH represents another adaptor protein of ClpC 
 
4.4.1 Comparison of MecA with YpbH 
 
YpbH is a paralog of MecA. The search of sequence databases with mecA as a query revealed 
the presence of a gene, ypbH, the product of which shows high similarity to MecA. The B. 
subtilis MecA paralog shares 26% sequence identity and 52% sequence similarity with the B. 
subtilis MecA on the amino acid level. MecA consists of two domains, the N- and C-terminal 
domains, with a linker region between them (Persuh et al., 1999). The similarity of YpbH to 
MecA extends over both domains, but YpbH is 24 amino acids shorter than MecA. ypbH is 
present in two other sequenced Bacillus species: Bacillus anthracis and Bacillus halodurans. 
It seems that ypbH is present only in the genus Bacillus while MecA, with a much broader 
distribution, is found in essentially all low-GC gram-positive bacteria (Bacillus, Listeria, 
Staphylococcus, Streptococcus, Lactococcus, and Enterococcus) The strong similarity of 
YpbH to MecA further implied that YpbH, like MecA, might bind to ClpC. YpbH is able to 
stimulate the ATPase activity of ClpC like MecA (data not shown). A ClpC YpbH interaction 
was shown by Persuh et al.2002 with surface plasmon resonance. The experiment depicted in 
Fig. 12 demonstrated that YpbH enables chaperone activity of ClpC. Both MecA and/or 
YpbH are without any preference, simultaneously recognized and degraded by ClpCP. And 
both can simultaneously target α-casein for degradation by ClpCP (see also Fig. 14).  
The ability of YpbH to refold chemically denatured luciferase and to disaggregate and refold 
heat denatured luciferase has been tested (Fig. 12) 
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Figure 12 A) refolding of heat denatured luciferase. ClpC together with MecA such as ClpC with YpbH can 
disaggregate and refold previously heat-aggregated luciferase. Previously heat aggregated luciferase was 
incubated with the indicated proteins and luciferase activity was determined at the indicated time points.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 B) Refolding of guanidinium hydrochloride denatured luciferase with KJE, ClpC, MecA, YpbH, ClpC 
and MecA or YpbH as shown in the legend. Luciferase activity was determined at the indicated time points. 
 
YpbH together with ClpC is able to disaggregate and refold luciferase, as MecA/ClpC does 
(Figure 12A). In addition the YpbH mediated activity to refold chemical denatured luciferase 
was comparable to ClpC/MecA 
These results demonstrate, that MecA and YpbH display identical chaperone activities. A 
deletion of ypbH affects competence development and sporulation. But unlike MecA, YpbH 
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does not target ComK for degradation. Both proteins have an influence on sporulation when 
overproduced, and in both cases this effect is dependent on ClpC (Persuh et al., 2002). 
 
 
4.4.2 Adaptor preferences of ClpC 
 
Both MecA and YpbH target themselves for degradation. To test which adaptor is favored, 
competition for degradation by ClpCP was examined. Equimolar amounts of MecA, YpbH 
and ClpCP were used in this assay. The results of these experiments depicted in Figure 13 
demonstrated that MecA as well as YpbH were degraded in less than 20 min (lane a +b). If 
both proteins are incubated together, no decrease in the degradation rate, of one of the adaptor 
proteins was observed (lane c). This result was also observed with higher concentrations of 
MecA (2µM) and YpbH (2µM) incubated together with ClpCP (1/1µM) (data not shown). 
Only the CTD of MecA is preferentially degraded, because in its presence the degradation 
rate of MecA and YpbH is slower (lane d + f).The degradation of the smaller CTD of MecA 
seems to be favored.  
As a control the effect of the presence of the N-terminal domain of MecA was tested for 
competition in the degradation of full length MecA and no influence was observed (lane e). 
 
a            b             c            d            e              f 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13) Coomassie stained gel of ClpC adaptor degradation. MecA (1µM) and YpbH (1µM) are degraded in 
less than 20 minutes (lane a+b). None of the adaptors are preferentially degraded if both are present (lane c) and 
equimolar amounts of ClpC/P are used. The C-terminal domain of MecA decelerates the degradation of full 
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length MecA as it does for YpbH (lane d and f). The N-terminal domain of MecA is not degraded and does not 
interfere with the MecA degradation (lane e). 
 
The presence of α-Casein lowers the MecA degradation rate, while it is presented as a 
substrate for ClpCP (Fig 14 b). YpbH mediates α-casein degradation (Fig 14 lane d) and the 
YpbH degradation rate was also lowered in presence of α-casein. To test whether MecA or 
YpbH is the preferred adaptor for substrate degradation both were incubated together with α-
casein (Fig 14 lane e). This experiment could demonstrate that one of these adaptors is more 
important for α-casein degradation and therefore different degradation rates of the adaptors 
should be observed.But in the experiment shown in Figure 14e no change of the degradation 
rates of MecA and YpbH has been observed in comparison to the degradation of these 
adaptors alone shown in Figure 14 lane b and d. The same results were obtained when the 
concentrations of MecA and YpbH were doubled (Fig.14 lane f). 
Two possible explanations for this observation exist. First, both adaptors bind at the same 
time on a ClpC hexamer (e.g. a ClpC hexamer bound with three molecules of MecA such as 
three YpbH molecules), second the complex out of ClpCP/MecA such as ClpCP/YpbH 
degrades free YpbH and MecA without any preference 
 
 
Fig. 14) Coomassie stained gel of adaptor mediated α-casein degradation. YpbH is able to degrade α-casein 
within 10 minutes (lane d, all proteins in a concentration of the 1µM). MecA and YpbH in equimolar amounts 
degrade α-casein in less than 10 minutes, but none of the proteins is degraded preferentially (lane e, all proteins 
1µM), also not if MecA (2µM) and YpbH (2µM) are higher concentrated (lane f). 
 
It remains to be elucidated if these adaptors share the same binding site of ClpC {??}, or if it 
is possible that both adaptors caninteract at the same time with one ClpC hexamer.  
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These results indicate, that MecA and YpbH are comparable in their chaperone activities, but 
in vivo different substrate specificity must exist because different substrates utilizes different 
adaptors (ComK and ComS are not degraded by YpbH) 
 
 
4.5 Oligomerisation of ClpC 
 
4.5.1 ClpC alone cannot form stable hexamers 
 
At this stage it was known that ClpC needed MecA for all observed activities such as ATPase 
hydrolysis, substrate targeting for degradation and chaperone activity.  
Experiments with different AAA+ proteins, like ClpA, ClpB or HSP104 already indicated, 
that the hexameric ring structure of HSP100/Clp proteins appeared to be a crucial prerequisite 
for their chaperone and ATPase activity (Hattendorf and Lindquist, 2002; Mogk et al., 2003a; 
Schirmer et al., 2001; Schlee et al., 2001). Therefore the oligomerisation abilities of ClpC and 
the influence of MecA on ClpC oligomerisation were investigated. 
Size exclusion chromatography and as a second method chemical cross linking with 
glutaraldehyde (GAXL) was used to analyze the oligomerisation status of ClpC in vitro.  
 
 
 
4.5.2 ClpC forms a monomer in Gelfiltration runs 
 
Unlike for most studied HSP100/Clp proteins, a hexamer of ClpC was not detectable by size 
exclusion chromatography.  
Gelfiltration runs performed with ClpC with or without ATP preincubation depicted only a 
peak consistent with the size of a monomer of ClpC (Figure 15) 
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Fig. 15) A monomer of ClpC but no higher oligomer was detected by size exclusion chromatography. ClpC (6 
µM) (preincubated with ATP (2mM)) were run on a S200 gelfiltration column. The elution profile of the protein 
detected at 220 nm is depicted in the graph. Arrows indicate positions of standard proteins with different 
molecular weights, separated on the same column. The fractions were analyzed by SDS-PAGE with subsequent 
silverstain and westernblot analysis  
 
This result was also obtained by a gelfiltration run with ATP in the running buffer (data not 
shown). Additionally the size of ClpC under these conditions has been determined using static 
light scattering measurements with a detector connected to a Äkta purifier with a S200 
gelfiltration column (Fig. 15). The molecular weight of the observed monomer of ClpC could 
be determined with this method to 96 kDa without ATP and to 100 kDa with ATP. In addition 
no peak consistent with a hexamer or higher molecular weight was observed with this very 
sensitive detection (data not shown). 
The oligomerisation behavior of ClpC has also been tested with chemical cross-linking with 
glutaraldehyde (GA). Since transient protein interactions are trapped by the chemical cross 
link, less stable oligomeric states of ClpC, which cannot be detected with size exclusion 
chromatography, could be detected with this method (Mogk et al., 2003b). 
ClpC was incubated with or without ATP; the cross link was initiated by the addition of GA 
and stopped by adding sample buffer. The samples were analyzed by gradient SDS-PAGE 
(4% - 15%) and visualized by silver stain. The results shown in Fig. 16 (lane 1-3) with or 
without ATP demonstrated that most of the total ClpC migrated as a monomer, but also a 
small amount of ClpC became detectable running at a size consistent with higher oligomeric 
forms of ClpC.  
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Fig. 16) In the presence of ATP, a small amount of ClpC, becomes detectable by chemical cross linking at the 
size of higher oligomeres. ClpC (1µM) was incubated with or without ATP (2mM) as indicated for the lanes in 
the panel on the bottom. Chemical cross linking was initiated by the addition of glutaraldehyde (GAXL) and 
stopped immediately (0’) or after 10 min incubation (10’) and analyzed on a SDS-PAGE gradient gel (4-15% 
acrylamide) with subsequent silver stain (Mogk et al., 2003b). For size determination see also Figure 18.  
 
 
4.5.3 MecA and ClpC are forming a heterodimer  
 
To test the influence of the Adaptor protein on the oligomerisation behaviour of ClpC, MecA 
was added in equimolar amounts to ClpC in the size exclusion chromatography experiments  
Fig. 17 shows the result of a typical gelfiltration run of ClpC together with MecA. Only two 
peaks became visible in the elution profile. The first peak appeared at a size corresponding to 
a heterodimer of ClpC and MecA and a second peak was detected running at the size 
observed previously for MecA (Persuh et al., 1999). Analysis of the fractions by SDS-PAGE 
and silver stain or Western-blot with Anti-MecA antibodies confirmed the suggested 
composition of the peaks. Similar results were obtained in experiments with or without ATP 
preincubation or ATP presence in the running buffer (data not shown). 
This suggests that ClpC and MecA can form a stable heterodimeric complex also in the 
absence of ATP 
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Fig. 17) a stable heterodimer of ClpC and MecA but no higher oligomer was detected by size exclusion 
chromatography. ClpC (6 µM) and MecA (6µM) were run on a S200 gelfiltration column. The elution profile of 
the protein detected at 220 nm is depicted in the graph. Arrows indicate positions of standard proteins with 
different molecular weights, separated on the same column. The fractions were analyzed by SDS-PAGE with 
subsequent silverstain and westernblot analysis  
 
 
4.5.4 MecA and ATP are necessary for the formation of ClpC oligomers 
 
The influence of MecA on ClpC oligomerisation with using the GA cross-link assay was 
examined. ClpC incubated with or without MecA or ATP. Chemical cross-linking was 
initiated by the addition of glutaraldehyde and stopped by adding sample buffer. In the 
presence of MecA, without the addition of ATP a band was noticeable, which could 
correspond to the ClpC-MecA heterodimer detected in the gelfiltration experiment (Fig. 18, 
lane 4). When MecA was added in the presence of ATP a strong effect on the size distribution 
of ClpC and MecA became visible. Under these conditions the majority of protein migrated at 
a size consistent with higher oligomeric forms of a ClpC/MecA complex and concurrently the 
monomer bands of MecA and ClpC were becoming less visible (Fig. 18, lane 5). 
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These findings suggested that in the presence of ATP a higher oligomeric complex containing 
both ClpC and MecA was formed. Interestingly this complex appears to be transient as it 
could only be detected by the GA cross-link experiment and not by size exclusion 
chromatography. As a size reference Fig. 18 also includes an additional GA cross-link 
experiment where the oligomerisation of ClpC with MecA and ClpC + MecA and ATP was 
directly compared with ClpB oligomerisation without ATP. This experiment also 
demonstrates, that in the absence of ATP most of ClpB migrated as higher oligomer 
 
compared to ClpC. 
ig. 18) In the presence of MecA and ATP, a higher oligomeric complex, not containing all the available ClpC, 
 
 on a SDS-
.5.5 ClpC-DoubleWalkerB(DWB) forms together with MecA a higher oligomer 
 has been demonstrated for some other AAA+ proteins that a mutation of the Walker B 
gh to be 
detected in a gelfiltration experiment in presence of ATP if the Walker B motif is modified 
F
becomes detectable by chemical cross-linking. ClpC (1µM) was incubated with or without ATP (2mM) or MecA
(1µM) as indicated for the lanes in the panel on the bottom. ClpB (1µM) oligomerisation was shown as a control 
for the size determination of intermediates. Chemical cross linking was initiated by the addition of 
glutaraldehyde (GAXL) and stopped immediately (0’) or after 10 min incubation (10’) and analyzed
PAGE gradient gel (4-15% acryl amide) with subsequent silver stain (Mogk et al., 2003b).  
 
 
4
 
It
motif, which prevents the hydrolysis of ATP but not its binding, can help to stabilize the 
higher oligomer form of these proteins(Babst et al., 1998; Hartman and Vale, 1999). 
Hartman et al. showed that the AAA+ protein p60 of Katanin is only stable enou
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(Hartman and Vale, 1999). To examine whether similar changes in the walker B motif of 
ClpC could result in the stable formation of hexameric ClpC, similar mutants forms of ClpC 
were constructed by K. Turgay with the help of C. Escher, where the conserved Glu of the 
Walker B motif in one or both ATPase domains were changed to an Ala (ClpC E280A (ClpC-
WB1), ClpC E618A (ClpC-WB2), ClpC E280A/E618A (ClpC-DWB)). The respective B. 
subtilis mutant strains (clpC-WB1; clpC-WB2 and clpC-DWB) have been constructed as 
described previously (Turgay et al., 2001).  
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GAXL experiments depicted in Figure 20 showed that without MecA only a small pro
o
a higher oligomer, the rest stayed as a monomer. In contrast to other AAA+ proteins like 
ClpB a stable hexamer of ClpC or ClpC-DWB without MecA could not be detected. 
Unlike for the experiment performed with ClpC (Fig 18), all the ClpC-DWB was shifted 
without detectable intermediates exclusively to the highest oligomeric state, in the pre
MecA and ATP (Lane 5). But in the presence of MecA without ATP (lane 4), similar to the 
experiment performed with ClpC; a major band appeared, which could represent the ClpC-
DWB MecA heterodimer (this was also detected by size exclusion chromatography (Fig 20)).  
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Fig. 20) In the presence of MecA and ATP the ClpC-DWB is detected by chemical cross linking almost 
exclusively in the higher oligomeric complex. GAXL experiments of ClpC-DWB (1 µM) with and without ATP 
(2 mM) and/or MecA (1 µM) as indicated, carried out like the experiment shown in Fig 18. ClpB (1µM) 
oligomerisation was shown as a control for the size determination of intermediates. 
 
 
Judged by the GA cross-link experiment the mutation in both Walker B motifs enabled the in 
vitro oligomerisation abilities of ClpC together with MecA but not in the absence of MecA. 
Therefore also size exclusion chromatography was used to analyze this higher oligomeric 
complex of ClpC-DWB and MecA, which appeared more uniform and stable compared to 
wildtype ClpC and MecA. Figure 21A depicts the gelfiltration run performed with DWB-
ClpC and MecA after preincubation of these proteins with ATP, but without ATP in the 
running buffer. A distinct complex consisting of DWB-ClpC, MecA was clearly detectable in 
the elution profile. The size of this complex (approximately 700 kDa) would be consistent 
with the size of a ClpC-DWB hexamer with up to six MecA molecules bound. The silverstain 
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in Fig. 21A supports the composition of the peaks, of ClpC and MecA as suggested for the 
protein peaks visible in the gelfiltration run. 
 
Fig. 21A) ClpC-DWB and MecA can form a stable higher oligomeric complex, which can bind substrate protein. 
The elution profile of size exclusion chromatography experiments with ClpC-DWB (6µM), MecA (6 µM) and 
α-casein (3H-labelled) (1 µM) (preincubated with ATP (2 mM) but without ATP in the running buffer) and the 
amount of radioactivity in the fractions are depicted in the graphs. Arrows indicate positions of standard proteins 
with different molecular weights, separated on the same column. The fractions were analyzed by SDS-PAGE 
with subsequent silverstain analysis  
 
The pre-incubation with ATP was essential for the formation of the higher oligomeric 
complex of ClpC and MecA. Using size exclusion chromatography in the absence of ATP and 
without preincubation of ClpC-DWB and MecA with ATP, only a ClpC-DWB MecA 
heterodimer, as demonstrated for MecA and ClpC was detected (data not shown).  
Fig. 21B depicts the silver stained gel of an SDS-PAGE of the fractions of a size exclusion 
chromatography of ClpC-DWB and MecA performed in the presence of ATP in the running 
buffer. It is evident that the higher oligomeric complex consisted of ClpC and MecA and that 
under these conditions all the ClpC was shifted to this higher oligomer, whose size is 
consistent with a ClpC-DWB hexamer and six MecA molecules.  
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ig. 21B) The fractions of a gelfiltration run of DWB-ClpC with 2 mM ATP in the running buffer were analyzed 
.5.6 Isolation of a ClpC/MecA/substrate complex 
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interaction with α-casein (3H labeled) was tested. α-Casein, an intrinsically unfolded protein, 
was degraded by ClpCP and MecA, so it was interesting to examine whether α-casein could 
associate with the higher oligomer complex of ClpC and MecA. 
Fig. 21A depicts that a distinct complex consisting of ClpC-DW
clearly detectable in the elution profile. This indicated that α-casein interacted directly with 
the higher oligomeric complex of ClpC-DWB and MecA. No substrate, coeluting with the 
transient heterodimer of MecA and ClpC was detected (data not shown). The suggested 
composition of the peaks, were confirmed by SDS-PAGE with subsequent analysis by 
Westernblot and silverstain. These experiments suggested that the higher oligomer complex 
of hexameric ClpC-DWB with MecA represents the active substrate-binding species of this 
chaperone system.  
The size of the ClpC
of α-casein, suggesting that α-casein encompassed in this complex. 
The ratio of MecA/ClpC was also lowered to six ClpC to one Me
MecA dependency of the ClpC-DWB oligomerisation and binding of α-casein Substrate 
interaction with the higher oligomer of ClpC-DWB and MecA was almost not detectable 
anymore with this amount of MecA (Fig. 22). 
Lowering the amount of MecA resulted also
oligomeric form of the hexamer ClpC with MecA to the intermediate ClpC-MecA 
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heterodimer fraction (Fig. 22). Without MecA no formation of the ClpC-DWB hexamer was 
detectable by size exclusion chromatography (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22) The elution profile of size exclusion chromatography experiments with ClpC-DWB (6µM), MecA (1 
µM) and α-casein (3H-labeled) 3µM (preincubated with ATP (2 mM) but without ATP in the running buffer) 
and the amount of radioactivity in the fractions are depicted in the graphs. Arrows indicate positions of standard 
proteins with different molecular weights, separated on the same column. 
 
 
These results suggest that the interaction of MecA with ClpC in the ATP bound state leads to 
the formation of a higher oligomeric complex, via a heterodimer intermediate. 
The complex of ClpC and MecA, which hydrolyze ATP, is not stable enough to be detected in 
a gelfiltration run. This complex can only be detected by gelfiltration, if ATP binding, but no 
ATP hydrolysis by ClpC is possible, like in the ClpC-DWB variant  
 
 
4.5.7 Further characterization of ClpC-DWB  
 
The ClpC-DWB mutant protein has been tested in MDH disaggregation/refolding and 
degradation of α-casein, but ClpC-DWB displayed no detectable activity in all these assays 
(data not shown). As a control also the MecA mediated ATPase stimulation of ClpC-DWB 
has been determined, but no ATP hydrolysis activity was measurable. To test the importance 
of the ATP hydrolysis activity of the ClpC monomers within the ClpC hexamer the ClpC-WT 
protein was mixed with ClpC-DWB protein in a ratio of 5:1 (WT: DWB) 
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The addition of ClpC-DWB to ClpC-WT at this stoichiometry inhibited all the MecA 
mediated ATPase activity of the WT protein and in addition all the ClpC-WT MDH 
disaggregation, refolding activity was completely blocked. This was also observed in α-
Casein degradation experiments (data not shown). 
On the other hand a negative influence of ClpC-WT on ClpC-DWB oligomerisation was also 
observed, because in a gelfiltration experiment no ClpC-DWB hexamers have been observed 
if ClpC-WT and ClpC-DWB were mixed in a 1:1 ratio; demonstrating that the formation of 
the ClpC-DWB- hexamers in presence of MecA was inhibited by ClpC-WT (data not shown). 
The result of these experiments are consistent with a mixed oligomer formation of ClpC-WT 
and ClpC-DWB, because ClpC-DWB inhibits the MecA mediated ATPase and chaperone 
activities of ClpC-WT and ClpC-WT inhibited the MecA mediated oligomerisation of ClpC-
DWB.  
In addition these experiments suggests that a cooperative ATP hydrolysis within the ClpC 
hexamer is essential for ClpC activity. 
 
 
4.5.8 The CTD of MecA is sufficient for assisting the oligomerisation of ClpC. 
 
To test whether full length MecA was required to assist the oligomerisation, or the C-terminal 
domain was sufficient the same experiments, as with full length MecA, were performed with 
the C-terminal domain (CTD, 16,8 kDa) of MecA 
The CTD of MecA is able to bind ClpC like full length MecA. This could be demonstrated 
with plasmon resonance experiments (see also Fig. 30). A heterodimer formation as observed 
for ClpC and MecA (Fig 15) can be detected with size exclusion chromatography (data not 
shown). The gelfiltration run shown in Figure 23A demonstrate that the CTD of MecA is 
sufficient to assist the oligomer formation of ClpC. This could also be detected with GAXL-
experiments (Fig 23B). 
In contrast to the higher oligomer of ClpC-DWB stabilized by MecA the CTD of MecA 
bound to the ClpC-DWB oligomer is not able to mediate substrate interaction, because α-
casein was not detected running with the higher oligomeric complex of ClpC-DWB and the 
CTD of MecA (Fig 23A). Although the CTD of MecA stimulate the ATPase activity of ClpC 
up to the same rates as full length MecA, no CTD of MecA mediated refolding or degradation 
activity have been detected as discussed in chapter 3.5. 
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23A        23B 
he CTD of MecA forms a 
MecA supports the oligomerisation of ClpC like MecA. ClpC (1µM) was incubated with or without 
 has been observed that the CTD of MecA is able to target itself for degradation (Fig. 25); 
Fig. 23) The CTD of MecA is sufficient to assist the oligomer formation of ClpC. T
higher oligomeric complex with ClpC-DWB. The elution profile of size exclusion chromatography experiments 
with ClpC-DWB (6µM), CTD-MecA (6 µM) and α-casein (3H-labeled) (3µM) (preincubated with ATP (2 mM) 
but without ATP in the running buffer) and the amount of radioactivity in the fractions are depicted in the 
graphs. Arrows indicate positions of standard proteins with different molecular weights, separated on the same 
column.  
(B) CTD-
ATP (2mM), MecA or CTD-MecA (1µM) as indicated for the lanes in the panel on the right. Chemical cross 
linking was initiated by the addition of glutaraldehyde (GAXL) and stopped after 10 min incubation and 
analyzed on a SDS-PAGE gradient gel (4-15% acrylamide) with subsequent silver stain.  
 
It
therefore it can be assumed that ClpC-WT possesses full activity. But without the substrate 
binding sites of the NTD of MecA, although higher oligomer formation of ClpC is possible 
(Fig.23), the CTD of MecA is not able to bind and subsequently to degrade α-casein (data not 
shown), which is consistent with the finding, that the NTD of MecA is necessary to target all 
other known substrates to ClpC (Persuh et al., 1999; Schlothauer et al., 2003). 
 
 
 
 87
   4 RESULTS 
4.5.9 Oligomerisation of ClpC by other adaptor proteins 
 
MecA is an adaptor for ClpC and enables the recognition and targeting of substrate proteins 
and simultaneously induces the ATPase activity of ClpC. The oligomerisation of ClpC 
mediated by MecA has most likely an important role in ClpC activity. The second adaptor 
protein YpbH displays the same activities needed for ClpC chaperone activity. For that reason 
also the YpbH mediated ClpC oligomerisation was investigated. Recently another possible 
ClpC adaptor McsB has been identified and tested for ClpC oligomerisation such as ATPase 
stimulation (J. Kirstein, K. Turgay unpublished data). 
McsB is a kinase that modulates the repressor of Class III heat shock genes (CtsR). CtsR, the 
protein encoded by the first gene of the four genes clpC operon, is the repressor of the class 
III heatshock genes, including clpC, clpP and clpE (see introduction). The second and third 
gene of this operon encodes McsA and McsB. A ∆mcsA strain behaves like a ∆ctsR strain and 
in a ∆mcsB strain the relief from repression by CtsR is inhibited. ClpCP was also shown to be 
responsible for the degradation of CtsR at high temperatures. Both ClpC and McsB have a 
negative and McsA a positive effect on CtsR activity or stability. (Krüger et al., 2001). 
McsB is similar to kinases and the N-terminal domain of McsA has Zn binding motifs and 
shows also similarity to the N-terminal domain of ClpX and ClpE. With purified components, 
it was tested whether McsA or McsB could have influence on ClpC activity in vitro. McsB 
but not McsA or CtsR induced specifically the ATPase activity of ClpC comparable to MecA 
(data not shown and personal communication, J. Kirstein). In vitro McsB could get degraded 
and could target McsA or CtsR for degradation by ClpCP (personal communication, J. 
Kirstein) 
To elucidate the role of the three known adaptors of ClpC in ClpC oligomerisation, MecA, 
YpbH and McsB were directly compared. The GAXL experiments shown in Fig 24 with 
ClpC and the different adaptors depicts, that MecA enables the oligomerisation as shown 
before (lane 1-3). YpbH forms the possible heterodimer with ClpC (lane 4) and stimulates the 
oligomerisation of ClpC (lane 5). McsB forms oligomeres of ClpC without visible 
intermediates in the absence of ATP (lane 6). With ATP and McsB the yield of ClpC 
hexamers is increased (lane 7).  
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Fig. 24) ClpC with and without ATP and different adaptor proteins (indicated at the lanes) were chemically cross 
linked with glutaraldehyde and analyzed by gradient SDS-PAGE with subsequent silverstain. 
 
The oligomerisation of ClpC by McsB was much more efficient compared to MecA and 
YpbH. McsB already mediates ClpC oligomerisation in the absence of ATP, and in presence 
of ATP the oligomerisation was as efficient as the MecA mediated ClpC-DWB 
oligomerisation (see figure 17B). Another difference to MecA and YpbH, visible in the 
GAXL, was that no McsB-ClpC heterodimer was detected. This result indicates that McsB is 
very important for ClpC activity in vivo. 
 
 
4.5.10 ClpC oligomers in vivo. 
 
To get an insight about the size distribution of ClpC, closer related to the in vivo situation, 
lysates from B. subtilis strains with and without carrying the clpC-DWB mutation were 
prepared. These lysates were separated by size exclusion chromatography and the fractions of 
the elution profiles were precipitated by MeOH and analyzed by SDS-PAGE with a 
subsequent western blot with anti-ClpC and anti-MecA antibodies. This analysis for all the 
fractions of the lysate of the wildtype cells is depicted in Fig. 25A. Higher oligomer forms of 
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ClpC were detected in these extracts, although the heterodimer form is more prominent. 
MecA was found to coelute with the higher-oligomer and heterodimer forms of ClpC. The 
direct comparison of fractions (Fraction 1 (void volume), Fraction 7 (higher oligomer) 
Fraction 21 (heterodimer) of the same experiment performed with wildtype strain compared 
to the clpC-DWB strain (Fig. 25B) revealed, that more higher-oligomer formed with ClpC-
DWB could be detected. A stronger interaction of MecA with ClpC-DWB could be the reason 
for the observation that more MecA seemed to coelute with ClpC-DWB compared to ClpC 
(Fig. 25B).  
Interestingly a rather strong signal was detected for both ClpC variants and MecA at the size 
where the protein complexes of apparent higher molecular weight run. This fraction could 
represent aggregated protein. This co-localization of ClpC and MecA to the aggregated 
protein fraction is consistent with previous studies, demonstrating that ClpC localizes in vivo 
to protein aggregates (Krüger et al., 2000) and that MecA can target ClpC to protein 
aggregates in vitro  
 
 
 
Fig. 25 A) Size distribution of ClpC and MecA in a lysate of a WT B.subtilis strain. The soluble fractions of the 
lysate were separated by size exclusion chromatography on a S300 column. The subsequent analysis by SDS-
PAGE and westernblot with Anti ClpC and Anti MecA antibodies of the eluted fractions from the 
chromatography is depicted. The detected proteins are indicated on the left and the estimated approximate 
molecular weight of the fractions, is indicated on top. On the right the pure proteins (pp) are loaded as a direct 
comparison. (I = Input, a dilution (1:8) of the lysate loaded on the column). 
 
 
 
 
 
 
Fig. 25B) Comparison of the distribution and relative amount of ClpC and MecA of lysates prepared from WT 
with clpC-DWB B.subtilis strains. The same amount of total protein was loaded on the S300 size exclusion 
column. The figure depicts the westernblot with anti-ClpC and anti-MecA antibodies, from one SDS-PAGE gel 
loaded with samples of the same volume and the same fraction from the two different runs. The lanes are named 
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according to the ClpC MecA species whose size they represent: vv (void volume, (Fraction 1)), ho (higher 
oligomer (Fraction 7)), hd (heterodimer, (Fraction 21)) and I (Input, a dilution (1:8) of the lysate loaded on the 
column). The strain the lysate originated from is depicted below and the detected proteins are indicated on the 
left. 
 
Taken together a size distribution for ClpC and MecA, including the heterodimer and higher-
oligomer forms can also be detected in lysates prepared from B. subtilis cells. This indicated 
that the in vitro observations of variable ClpC and MecA distribution could be applied to 
describe the in vivo situation. 
 
 
4.6 Interaction of ClpC and MecA. 
 
4.6.1 Role of the Walker B motif in AAA-1 and AAA-2 
 
The mutation in the Walker B motifs one and two were used as a tool to elucidate the 
importance of the AAA1 and AAA2 in ClpC activity. With these mutants the activity of one 
Domain could be investigated, while the other is blocked in the ATP bound state. 
First the ATPase activity of ClpC-WB1 and ClpC-WB2 was measured, which displayed the 
same basal rate as ClpC (0.004 s-1). The induction of the ATPase of ClpC-WB1 by MecA (in 
a 1:1 ratio) ((0.03 s-1+/- 0,01 s-1) 7x the basal rate) was in the same range as the ATPase 
induction of ClpC-WB2 ((0.03 s-1+/- 0,02 s-1) 7x the basal rate). Both mutants were tested in 
the d
 
 
 
 
 
 
egradation of the C-terminal domain of MecA (Fig. 26).  
ig. 26) Degradation of C-terminal MecA, ClpC-WT, ClpC-WB1 and ClpC-WB2 were incubated with ClpP, 
TP and PK/PEP regenerating system. Samples were taken at indicated time points and analyzed by coomassie-
stained-SDS-PAGE. Proteins are marked on the right side of the gel. 
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In comparison to WT-ClpC (degradation completed after 10 min.), ClpC-WB1 and ClpC-
B2 degraded the C-terminal domain of MecA much slower. Thus the low ATPase induction 
as sufficient for ClpC-WB1 and ClpC-WB2 to degrade CTD-MecA. The ClpC-WB2 mutant 
CTD of MecA. In an additional experiment ClpC-WB1 and ClpC-WB2 has been tested to 
degrade α–casein in presence of MecA, but no degradation of α–casein has been observed. 
The low ATPase activity of the ClpC-Walker B mutants seems not to be sufficient for any 
 
 
 
ig. 27 
 µM) (
rrows i
) GA
M) as i
W
w
is able to degrade the CTD of MecA faster than the ClpC-WB1 mutant, suggesting that the 
hydrolysis activity of the first Walker A domain is more important for degradation of the 
degradation of α–casein (data not shown). 
MecA dependent oligomerisation of ClpC-WB1 and ClpC-WB2 were also examined by size 
exclusion chromatography and GAXL,  
 
 
 
27A) 27B) 
A+B) The elution profile of size exclusion chromatography experiments with ClpC-WB1 (6µM) MecA 
preincubated with ATP (2 mM) but without ATP in the running buffer) are depicted in the graph (A). 
ndicate positions of standard proteins with different molecular weights, separated on the same column. 
XL experiments carried out with ClpC-WB1 (1 µM), with and without ATP (2 mM) and/or MecA (1 
ndicated and as described for the experiment shown in Fig 17.  
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The experiments depicted in Figure 27A and 28A demonstrated that ClpC-WB1 and ClpC-
B2 could form the heterodimer with MecA and both could form the higher oligomers 
induced by MecA and ATP determined by the GAXL experiment (Fig 27B and 28B), but 
nly ClpC-WB1 and not ClpC-WB2 could form a stable higher oligomeric complex with 
ecA, which could be detected by size exclusion chromatography (Fig 27A). 
Fig. 28 A+B) The elution profile of size exclusion chromatography experiments with ClpC-WB2 (6µM) MecA 
(6 µM) (preincubated with ATP (2 mM) but without ATP in the running buffer) is depicted in the graph (A). 
Arrows indicate positions of standard proteins with different molecular weights, separated on the same column. 
(B) GAXL experiments carried out with ClpC-WB2 (1 µM), with and without ATP (2 mM) and/or MecA (1 
µM) as indicated and as described for the experiment shown in Fig 17.  
 
To test the binding of ClpC-DWB, ClpC-WB1 and ClpC-WB2 to the CTD of MecA surface 
plasmon resonance analysis were performed. These experiments demonstrated that all the 
Walker B mutants are able to bind the CTD of MecA as ClpC-WT (data not shown). 
In summary the ClpC-WB1 behaves more like the DWB-mutant. The abilities of both Walker 
B mutants to form a heterodimer with MecA are similar as shown by the biacore analysis, 
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gelfiltration and GA cross-linking, but the experiment in Fig. 27A demonstrated that the 
ClpC-WB1 is able to form higher oligomers in presence of MecA stable enough to be 
detected by gelfiltration experiments. Also a stronger defect in degradation of the CTD of 
MecA has been shown for the ClpC-WB1 mutant suggesting that the ability of the 
translocation of the substrate (as shown by (Reid et al., 2001))is inhibited more than for ClpC-
WB2, or a more stable interaction of the CTD of MecA with ClpC-WB1 inhibit the 
degradation of this substrate. 
The results shown for the ClpC-WB1 mutation and the ClpC-WA1 (K214Q) (Turgay et al., 
2001) imply that the determinants for MecA interaction could be located in or close to the 
AAA1 of ClpC. 
 
 
4.6.2 The N domain and the Linker domain of ClpC are crucial for MecA association 
 
An extra domain in AAA-1 unique for the ClpC subfamily (Schirmer et al., 1996) is the 
attached Linker domain. The Linker domain of ClpC is homologous to the Linker from ClpB 
from Thermus thermophilus, which forms a coiled coil structure (Lee 2003). This Linker is 
likely to play a role in protein-protein interactions. Another domain connected directly to 
to be important in substrate, or adaptor interaction (Dougan et al., 2002a) as it was shown for 
To examine the hypothesis that these domains could be responsible for the MecA and ClpC 
interaction, variants of ClpC missing the NTD (ClpC-∆N) or the Linker domain (ClpC-∆Li) 
have been constructed. To investigate whether ClpC-∆N and ClpC-∆Li have folding defects, 
AAA1 is the N-terminal domain (NTD) of ClpC (Fig 29). The NTD of the Hsp100 is known 
the NTD of ClpA and its adaptor protein ClpS (Zeth et al., 2002b). 
 
Fig. 29) Schematic view of the domain organisation of the ClpC∆N and ClpC∆Li-mutants 
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due to the deletion of whole domains in the size of the NTD (141aa) and the Linker (58aa), 
the mutant proteins were analyzed in comparison to WT-ClpC by circular dichroism (CD) 
 secondary structure were observed and the peak between 190 and 200 nm 
howed that the absorbtion of the α-helical parts of all proteins was in the same range. 
dditionally all proteins had a minima at 208 nm and 222 nm which is characteristic of a α-
rom the 
TD and the Linker in the ClpC-∆N and ClpC-∆Li proteins. As an example the wavelength 
 
 
 
 
 
 
 
 
 
 
 
ig. 30A) Six different wavelength scans with ClpC-WT, ClpC-∆N and ClpC-∆Li have been performed with 
ements the part of α- 
elices visible in the peak between 190 and 200 nm, was basically the same in WT and mutants. As an example 
e wavelength scan at 30 °C is shown in this figure. 
 
 
measurements. For that CD measurements were performed at different temperatures (Fig 26). 
From the CD-spectra performed at 20°C/30°C/37°C/40°C/50°C and 60°C no major 
differences in the
s
A
helical structure. Minor differences can be ascribed to the absence of the α-helices f
N
scan at 30 °C is shown in figure 30A. To visualize the transition states during unfolding the 
ellipticity at 220 nm was measured in a temperature scan between 10°C and 85°C (Fig. 30B) 
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WT-ClpC 
∆N 
∆Linker 
 
Fig. 30B) Overlay of the temperature scan at 220 nm of ClpC-WT (blue), ClpC-∆N (green) and ClpC-∆Li (red). 
he temperature transition states are at the same temperatures for the WT and ClpC- ∆N and ClpC-∆Li. 
he comparison of the temperature transition states reveals that around 40°C the temperature 
epended unfolding of ClpC-WT, ClpC-∆N and ClpC-∆Li take place. The second transitions 
 total unstructured proteins are around 60°C. The resulting melting temperature were 
8,51°C for ClpC-WT, 50,79°C for ClpC-∆N and 45,66°C for ClpC-∆Li. 
lpC-∆N and ClpC-∆Li were tested in several assays for their basal and MecA induced ATP 
ydrolysis rate and chaperone activity, but beside a basal rate comparable to ClpC-WT no 
irst the ability of ClpC-∆N and ClpC-∆Li to bind to the C-terminal domain of MecA in 
omparison to ClpC-WT was tested by surface plasmon resonance.  
o interaction of ClpC-∆N with the CTD of MecA was detectable and ClpC-∆Li displayed 
eak interaction with the CTD of MecA under these conditions (Fig 31). In another biacore 
experiment J.Kirstein and K.Turgay showed some interaction of ClpC-∆N and also some 
ore binding of ClpC-∆Li with the CTD of MecA. But these interactions were still weak in 
omparison to the signal of ClpC-WT. 
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T
d
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MecA stimulated ATPase rate and no chaperone activity has been observed (data not shown) 
Additionally binding to MecA, heterodimerformation in gelfiltration runs and GAXL-
experiments has been analyzed (see Figure 32-34). 
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Fig. 31) Comparison of ClpC, ClpC-∆N and ClpC-∆Li binding to MecA, by surface plasmon resonance. The 
inding response is measured in resonance units (RU). About 500 RU of the N-terminally his-tagged CTD-
 
wn).  
 at the size of a MecA 
 
 
 
b
MecA was bound on a Ni-NTA affinity chip and ClpC, ClpC-∆N or ClpC-∆Li proteins (200 nM) (with 2 mM 
ATP) were passed over the chip surface. After 60 s buffer with 2.0 mM ATP was introduced and buffer lacking 
ATP was passed over each chip after 120 s. 
 
This low response of the mutants indicates that NTD and the Linker play a role in MecA 
interaction, but only MecA binding and no other activity could have been detected with this 
experiment. 
For both ClpC variants no ClpC MecA heterodimer was detectable by gelfiltration with and 
without ATP preincubation (Fig.32 and data not sho
Subsequent westernblot and silverstain analysis of the fractions of the gelfiltration run with 
ATP preincubation depicts that most of the MecA was detectable
monomer in the western blot at the position of ClpC (Fig. 33A+B). 
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Fig 32) The elution profiles of size exclusion chromatography experiments with ClpC (6µM), ClpC-∆N (6µM) 
and ClpC-∆Li (6µM), all with MecA (6 µM) with ATP (2 mM) Arrows indicate positions of standard proteins 
with different molecular weights, separated on the same column.  
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ig. 33 A+B) The fractions from the gelfiltration run shown in Fig. 31 were collected and analyzed by SDS-
AGE with subsequent silverstain and westernblot analysis  
A cross-link experiments demonstrated, that due to the deletion of the NTD, MecA could 
either interact nor form the heterodimer with ClpC anymore. The deletion of the linker 
showed the same behavior, although a weak interaction of MecA with ClpC-∆Li was still 
etectable, indicating that the NTD of ClpC is the primary interaction site, which together 
ith the linker domain could constitute the MecA receptor. Consequently MecA could not 
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assist the oligomerisation of ClpC-∆N or ClpC-∆Li as demonstrated by GAXL experiments 
ig 34). The deletion of the NTD did not interfere with the ability of ClpC to form transient 
oligomers, because a minor fraction of transient higher oligomers, comparable to ClpC (Fig 
6), was detected by GAXL for ClpC-∆N (Fig 34 lane 6). But MecA could not stabilize or 
ssist the formation of this higher oligomer (lane 7 and 8 Fig 34). A higher oligomer form of 
lpC-∆Li could not be detected with or without MecA (Fig 34 lane 1-4), even at higher 
concentrations (data not shown). The presence of the linker domain might be important for 
e oligomerisation ability of ClpC.  
 
 
ig. 34) GA cross-link experiments carried out with ClpC-∆N (1 µM) and ClpC-∆Li (1 µM) with and without 
TP (2 mM) and/or MecA (1 µM) as indicated and as described for the experiment shown in Fig 16. 
The GAXL experiments with ClpC-∆N and ClpC-∆Li depicted that both proteins do not form 
ligomers in presence of MecA. 
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4.7 In vivo phenotype of ClpC mutants 
 
To elucidate the in vivo Phenotypes of ClpC-DWB, ClpC-∆Linker, ClpC-WB1 and ClpC-
WB2 the mutants were tested under heat shock conditions shown in growth curves and spot 
2,5
3
ClpC-WT
ClpC-DW
tests. 
ig 35) Growth curve of ClpC-WT, ClpC-DWB, ClpC-∆Linker, ClpC-WB1 and ClpC-WB2. Cells were 
ulated in 2YT medium from fresh grown cultures with the same number of cells (OD600 =1.0). At an OD600 
f 0.6 the cells were shifted from a 37°C to a 54°C water bath and samples were taken at the indicated time 
oints.  
The graph shown in Fig. 35) indicates that the clpC-DWB mutant has the strongest growth 
d Walker 
2 mutants have only minor defects, coherent with the observation that they are able to fulfill 
ved (data not shown) 
pot tests were performed in addition to elucidate the differences in growth under constant 
eat shock conditions. The fresh inoculated cultures of the strains clpC-WT, clpC-DWB, clpC-
∆Linker, clpC-WB1 and clpC-Wb2 were diluted to the indicated OD600 = 1.  
0
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defect under these conditions, followed by ClpC-∆Linker. The single Walker B1 an
B
minor ClpC-WT activities in vitro. At 37°C no growth differences of the mutant strains in 
comparison to the WT were obser
S
h
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An aliquot of these dilutions were spotted onto LB-plates and incubated at different 
mperatures (37°C, 52°C and 53°C). At 53°C a strong difference of the phenotype was 
 
 
 
 
 
 
 
 
 
Fig. 36) Spot test of clpC-WT, clpC-DWB, clpC-∆Linker, clpC-WB1 and clpC-WB2. Cells were inoculated 
with the same number of cells from fresh grown cultures. Dilutions of the cultures were spotted onto LB plates 
and placed in incubators with different temperatures. The Plates placed at a 53°C-incubator was shown in this 
figure (53°C LB kindly provided by A.Mogk). 
 
On TBAB or LB plates no colonies of the clpC-DWB strain were observed at 53°C. The cells 
observed (Fig. 36). The clpC-WB1 and WB2 mutant strains displayed under these conditions 
growth limitation under high temperatures. At normal temperatures no differences in growth 
are visible in comparison to the clpC-WT strains.  
In another in vivo experiment the ability of these mutants to inhibit ComK activity in 
comparison to clpC-WT was tested. To determine the competence phenotypes of the clpC 
mutant strains, the β-galactosidase activities of P –lacZ reporter fusions, integrated at the 
followed (Fig. 37). The comK–lacZ fusion actually reports the cellular content of active 
ComK, as this protein is needed for the expression of its own gene (van Sinderen and 
Venema, 1994). As expected, the control strain with a wildtype clpC gene exhibited a minor 
increase in β-galactosidase activity after the transition to stationary phase (4h).  
te
observable (Fig. 36).  
 
 
of the clpC-∆Linker strain showed growth of some colonies in a dilution of 10-3. The strains 
clpC-WB1 and clpC-Wb2 grow in 2YT medium after a heat shock like WT (Fig. 35), but in 
the spot tests differences between clpC-WB1 and clpC-WB2 in comparison to the WT were 
clear growth limitations. But opposite to the in vitro data, the clpC-WB2 displays stronger 
comK
ectopic amyE locus of these strains and the growth of the strains in competence medium were 
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Fig. 36) Effects of clpC mutations on comK–lacZ expression. Cells were grown in competence medium (Spiz II-
medium) and samples were taken at the indicated time points to be tested for β-galactosidase activity. Miller 
Units are calculated from the average of two experiments. 
The ∆-Linker mutation showed a dramatic effect. This mutant strain behaved like other 
B.subtilis cells with a clpC knockout (data not shown). This was another indication that ClpC-
∆ as unable to bind MecA and thereby inhibit ComK activity. β-Galactosidase 
to the fact that MecA can be bound even tighter than ClpC-WT to this mutant proteins (as 
 previous in vitro data shown for the ClpC-
 
-Linker w
activity was also detected in the strains with the mutation in the walker B motifs. This suggest 
that ComK activity is also not inhibited by ClpC-DWB, ClpC-WB1 and ClpC-WB2 but due 
shown in Chapter 4.6) this effect is not as strong as for ClpC-∆-Linker. 
The findings shown in chapter 4.7 corroborate the
∆-Linker and the importance of ATP hydrolysis activity of Domain 1 and 2 (AAA1 & 
AAA2), because also the in vivo activity of these proteins is affected.  
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5 DISCUSSION 
 
5.1 ClpC and MecA - a bi-chaperone system 
 
The results presented in this work demonstrated that adaptor proteins like MecA or YpbH are 
necessary for the in vitro disaggregation and refolding of protein aggregates by ClpC, a 
chaperone of the HSP 100 subfamily. MecA is also necessary for the in vitro proteolysis of 
unfolded or aggregated proteins by ClpCP. These adaptors enables the recognition and 
targeting of substrate proteins to ClpC and simultaneously induces the ATP hydrolysis of 
ClpC. ClpC is activated by MecA, which acts as an assembly factor for ClpC, by interacting 
with the N-domain and the Linker of the ClpC monomer. This activity of MecA is observed 
for the first time for adaptor proteins of AAA+ proteins. 
 
5.1.1 Adaptor controlled oligomerisation of ClpC 
 
A monomeric state is unusual for HSP100 proteins, because the hexamer of HSP100/Clp 
proteins appear to be a crucial prerequisite for their activity. It should also be kept in mind 
at the mechanism by which HSP100/Clp proteins recognize, unfold and translocate 
ity and the oligomeric 
 total ClpC population, 
aches a higher oligomer, presumably hexamer form in the presence of ATP.  
 the presence of MecA, ClpC or the ClpC Walker B mutants and the adaptor protein form 
n intermediate heterodimer independent of the presence of ATP. This heterodimer is shifted 
wards a higher oligomeric complex of ClpC together with the adaptor protein only in the 
resence of ATP or ADP (data not shown). It could be demonstrated that this higher 
oligomeric complex of ClpC and MecA is the active complex of this chaperone system, 
th
substrate protein, preparing them for the peptidase ring, is mostly consistent with ring forming 
HSP100/Clp proteins as the active species. That a hexamer of an HSP100/Clp protein 
interacts and processes substrate was in fact directly observed for e.g. ClpA and ClpX 
(Ishikawa et al., 2001; Kim et al., 2001; Ortega et al., 2000; Reid et al., 2001). A clear 
correlation of ATPase and chaperone activity and oligomeric state was also observed for 
ClpB (Mogk et al., 2003b; Schlee et al., 2001) and Hsp104 (Hattendorf and Lindquist, 2002; 
Schirmer et al., 2001), but how are the ATPase and the chaperone activ
state of the HSP100 protein ClpC controlled ?  
This study demonstrated, that in the absence of an adaptor protein, most of the ClpC 
population resides in a monomer form and only a minor fraction of the
re
In
a
to
p
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because a complex of ClpC-DWB and MecA can interact with substrate proteins (Fig.21A). 
he estimated size of this complex is consistent with a hexamer of ClpC interacting with up to 
s consistent with the observation that the 
haperone activity of ClpC and MecA reached a maximum at a ratio of six MecA molecules 
full length MecA for the chaperone 
ctivity of ClpC-MecA system (Fig 10). 
ever, as this study demonstrates, MecA is also 
 and degraded 
T
six molecules of MecA. This composition i
c
to one ClpC hexamer (Fig.11).  
Persuh et al. demonstrated that the adaptor protein MecA possesses an N-terminal (NTD) 
substrate interaction domain and a C-terminal (CTD) domain necessary for ClpC binding and 
stimulation of the ATP hydrolysis rate of ClpC (Persuh et al., 1999). The CTD of MecA was 
sufficient to initiate the assembly of the active complex of ClpC and MecA, but only in the 
presence of full length MecA, can a substrate protein, α-casein, also co-migrate with the 
higher oligomeric complex (Fig. 18). This demonstrated that the NTD of MecA is an 
indispensable prerequisite for substrate recognition and 
a
 
 
5.1.2 Adaptor mediated substrate recognition 
 
Beside the MecA mediated oligomerisation of ClpC the MecA mediated substrate recognition 
is very important for the ClpC chaperone activity. Adaptor proteins, like MecA, bound to 
their cognate HSP100/Clp proteins, could enable, diversify, and expand substrate recognition 
and thereby raise the overall affinity for complex substrates like aggregated proteins. Studies 
on E. coli ClpX showed that the simultaneous multiple recognition of substrates like λO is an 
important prerequisite for the disaggregation and refolding activity by HSP100/Clp proteins 
(Gonciarz-Swiatek et al., 1999; Wawrzynow et al., 1995). 
MecA was considered a specific regulatory adaptor for the recognition of ComK and ComS 
(Persuh et al., 1999; Turgay et al., 1998). How
able to target parts of unfolded proteins in protein-aggregates to ClpC. But MecA is not only 
important for the recognition and disaggregation of protein aggregates, it is also necessary for 
efficient recognition of unfolded proteins, like α-casein, which are recognized
by other AAA+ proteins (e.g., ClpAP or Lon) without any adaptor protein.  
The MecA-dependent ATPase of ClpC is significantly induced by ComK and ComS (Turgay 
et al., 1997) but for yet unknown reasons not significantly induced by α-casein, distinguishing 
these substrate classes. Little is known about the substrate specificity of MecA, besides the 
interaction of ComK and ComS with the N-terminal domain of MecA (Persuh et al., 1999). 
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The N-terminal domain of MecA is also necessary for the recognition of heat-aggregated 
proteins. The recognition sequences located in ComK and ComS may be similar to those 
recognized by MecA in unfolded or aggregated proteins. Consistent with this idea, NMR 
studies suggest for ComS an unfolded state (J.Cavanagh).  
Taken together, these findings strongly suggest that, in contrast to E.coli ClpA, ClpC alone 
 of ComK in competence development (Persuh et al., 
002). This study demonstrates that YpbH also induces the ATPase activity of ClpC and 
nables ClpCP to degrade α-casein and to disaggregate and refold Luciferase aggregates (Fig. 
 ClpC judged by the GA crosslink assay (Fig. 
7). A third adaptor protein for ClpC McsB, which is no paralog of MecA was recently 
i adaptor-like co-
cannot select and recognize substrates and that adaptor proteins like MecA are necessary for 
all of the functions of ClpC, including substrate recognition. 
 
 
5.1.3 Other ClpC adaptors 
 
Interestingly, in B.subtilis YpbH a paralog of MecA exists. This protein, however, is not 
involved in the targeting and degradation
2
e
34). YpbH also assists the oligomerisation of
3
identified and is currently analyzed. McsB displayed similar adaptor and activator abilities, 
including the assistance of ClpC oligomerisation (J. Kirstein, T.S., Ulf Gerth, Michael Hecker 
& K.T., in preparation and Fig.37).  
Since MecA is known to be a specific regulatory adaptor it has been tested whether ClpC 
favor YpbH to target more general substrates e.g. α-casein but no preferences between MecA 
and YpbH have been observed (Fig 14). 
 
 
5.1.4 Comparison to adaptors in E.coli 
 
The activity control of ClpC by the adaptor protein MecA is also new in comparison to the 
functions of the known adaptor proteins in E.coli. Until now adaptor proteins of E. coli was 
only known as modulators of HSP100/Clp activity. The function of E. col
factors of Clp proteins differs from the ClpC-MecA system, because they are not necessary 
for the chaperone function of their cognate HSP100/Clp or Lon homologues and they do not 
induce their ATPase activity or function as substrates. RssB takes part in specific and 
regulated recognition of the σ Factor σS by ClpXP (Becker et al., 1999; Zhou et al., 2001). 
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SspB a ribosome associated protein helps recognizing and targeting SsrA tagged proteins for 
degradation by ClpXP (Levchenko et al., 2000). Recently even a simple non-proteinaceous 
adaptor namely inorganic polyphosphate, targeting free ribosomal proteins for degradation by 
Lon, was identified in E. coli. (Kuroda et al., 2001).  
 
 
5.1.5 Role of MecA and YpbH in vivo 
 
This work demonstrated that an adaptor protein is an important prerequisite for ClpC 
ne activity in vitro, due to this fact the role of MecA and YpbH 
hould be also very important for ClpC activity in vivo. 
re. However, when additional MecA is supplied on a 
ent of MecA and ClpC in multiple 
gulatory processes, considerably more effort will be required to dissect these functions in 
ivo.  
 synthesis of clpC or clpP mRNA, neither mecA nor 
pbH transcription is heat shock-regulated (Helmann et al., 2001; Petersohn et al., 2001; Price 
oligomerisation and chapero
s
The presented results indicate that MecA and YpbH may have a general and complementary 
function in protein quality control. MecA homologs are found in all sequenced genomes of 
low GC Gram-positive bacteria, which also always encode ClpC homologs but not necessarily 
ComK homologs. Other known ClpCP substrates from B. subtilis, like Spx (Nakano et al., 
2002b) or CtsR (Krüger et al., 2001), need MecA for the in vitro degradation by ClpCP 
(Nakano et al., 2002b)(and data not shown). Studies on the role of ClpC in sporulation 
suggested that more adaptor proteins for ClpC could exist (Pan and Losick, 2003). 
A mecA ypbH double-mutant strain is not defective in thermosensitivity, as measured by 
growth on plates at high temperatu
plasmid in trans (Persuh et al., 1999), B. subtilis cells are rendered more thermosensitive 
(Schlothauer et al., 2003), suggesting that MecA may function in the protein quality control 
system in vivo. Nevertheless, because of the involvem
re
v
It has been shown before that unlike the
y
et al., 2001), although recent studies demonstrated that mecA transcription levels are induced 
14,6 fold after 30 minutes of disulfide stress (Leichert et al., 2003) and 3,3 fold after an 
oxidative stress (Mostertz et al., 2004). 
It was already observed in vivo and in vitro that MecA is also a ClpCP substrate (Msadek et 
al., 1998; Turgay et al., 1998). We observed in vitro that the presence of model substrates like 
α-casein also stabilizes MecA (Fig. 7). Therefore, it is tempting to speculate that the 
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availability of MecA substrates could regulate the cellular level of MecA, as proposed by 
Msadek et al. (Msadek et al., 1998) based on their in vivo observations.  
 
 
5.1.6 Competition of substrates for ClpC binding in vivo 
 is focused on the degradation of the first identified 
ubstrates ComK and ComS. Is there a competition between this substrates and aggregated 
ce develops only under very specific 
er, is the disaggregation and refolding activity of ClpC and MecA also required in 
P may involve MecA also in vivo in the degradation 
competition between the different Clp-ATPases (ClpC, ClpE and ClpX) for ClpP in B.subtilis, 
 
The proteolytic system ClpCP/MecA
s
proteins in vivo? Under normal growth conditions the ComK turnover can be handled by a 
fraction of the available MecA and ClpCP (Turgay et al., 1998). ComK is not synthesized in 
heat-shocked cells (Turgay et al., 2001), and competen
conditions where protein aggregation does not play a role. This indicates that a direct 
competition between ComK and misfolded or aggregated proteins should not pose a problem 
in vivo, but it is also not elucidated if ClpC and MecA refold aggregated proteins or this 
proteins are degraded by ClpCP and MecA. 
 
 
5.1.7 Is there disaggregation or degradation of ClpCP substrates? 
 
As shown in this work, ClpC is able to disaggregate and refold protein aggregates in vitro, 
together with MecA, but in presence of ClpP, ClpC associates with the peptidase subunit and 
form a proteolytic complex. Comparing the degradation rate of aggregated MDH with the rate 
of disaggregation with subsequent refolding showed that the degradation is faster than the 
refolding of proteins (Fig. 8 and Fig.6A) 
Howev
vivo? 
It has been demonstrated that B. subtilis ClpC, ClpX, and ClpP associate in vivo with protein 
aggregates and inclusion bodies and in addition, their involvement in the in vivo degradation 
of misfolded proteins has been shown (Jürgen et al., 2001; Krüger et al., 2000). The results 
presented in this work suggest that ClpC
of misfolded proteins. On the other hand ClpC and MecA should be able to display chaperone 
activity in vivo if not all ClpC oligomeres are occupied by the proteolytic subunit ClpP. 
However Gerth and co-workers (Gerth et al., 2004) showed, that there is obviously no 
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either under standard growth conditions or in the presence of heat shock. According to their 
calculation, a maximum of approximately 75% of the total Clp ATPase-binding sites on ClpP 
an be occupied by Clp ATPase subunits during standard growth (37°C), and only about 60% 
an be occupied after heat shock even if all Clp proteins are present at their maximal level at 
ut it has been shown that HSP100/Clp proteins and also ClpC can have dual functions as a 
.2 Mechanism of MecA mediated oligomerisation of ClpC 
he pre-existing monomeric ClpC will be rendered 
s immediately available on demand for different physiological or regulatory purposes at 
c
c
the same time. 
B
chaperone and as part of a protease complex (Burton et al., 2001; Turgay et al., 1998; Turgay 
et al., 1997; Wickner et al., 1994). In addition the B. subtilis genome does not encode an 
ortholog of ClpB of E. coli. Therefore ClpC and MecA could fulfill this disaggregation 
function in B. subtilis, as suggested by the presented in vitro results.  
The involvement of the possibly redundant functions of ClpE, ClpX, the MecA paralog 
YpbH, and their functional interplay with other chaperone systems, like KJE and GroEL/ES of 
B.subtilis, in disaggregation and refolding or degradation remains to be elucidated.  
 
 
 
5
 
 
5.2.1 Adaptor proteins control ClpC oligomerisation  
 
To activate ClpC by assisting its oligomerisation via different adaptor proteins with e.g. 
different substrate affinities or targeting abilities is a very effective and new control 
mechanism of an HSP100/Clp protein. T
inactive, unless activated by an adaptor protein after formation of a heterodimer. Thereby 
ClpC i
various times and cellular locations. This process is fully reversible, because MecA can also 
become a substrate for ClpC in the absence of other substrates (Fig. 7), thus the assembly 
factor is degraded and the ClpC complex disassembles. 
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5.2.2 Heterodimer formation between ClpC and MecA 
 
The heterodimer of ClpC and MecA is an intermediate step and a prerequisite, ultimately 
resulting in the formation of the active higher oligomer of ClpC and MecA. No interaction of 
the substrate protein with the ClpC-MecA heterodimer was observed. Interestingly the 
o identify the role of both AAA domains for ClpC activity, ClpC-WB1 and ClpC-WB2 were 
sted for ATPase induction the remaining degradation activity and especially for the MecA 
ediated oligomerisation. 
C-WB2 and its correlation to 
eir activity could reflect, at least partially, the activity of the ClpC-WB1 and ClpC-WB2 
examers, because of the correlation of the MecA dependent ATPase and the chaperone 
ratio, where the chaperone activity was 
t a maximum, could be as high as 1.1 s-1 (Table 1), which was 35 times more than the MecA 
s to be also important for ClpC 
ctivity. Experiments with the ClpC-DWB mutant showed, that ClpC-DWB inhibits at a ratio 
f 1:5 the MecA mediated ATPase and chaperone activities of ClpC-WT (see chapter 4.8.6). 
he in vivo phenotypes of ClpC-WB1 and ClpC-WB2 showed a less strong effect than the in 
itro observations. Competence measured by β-Galactosidase activity of a PcomK-lacZ 
porter fusion and heat resistance measured by growth at high temperature (Turgay et al., 
heterodimer formation detected by size exclusion chromatography appeared to be independent 
of ATP, which was confirmed by protein interaction studies demonstrating that MecA 
interacted with ClpC, ClpC-DWB, ClpC-WB1 and ClpC-WB2 independent of ATP (data not 
shown and (Turgay et al., 2001)).  
 
 
5.2.3 Role of the individual AAA-domains in MecA binding 
 
T
te
m
The observed MecA induced ATPase of ClpC-WB1 and Clp
th
h
activity. The MecA induced ATPase of ClpC at a 1:1 
a
induced ATPase of ClpC-WB1 and ClpC-WB2. The remaining ATPase activity of ClpC-
WB1 and ClpC-WB2 appeared to be sufficient for some remaining activity. Both ClpC single 
WB variants were still able to degrade the CTD of MecA in vitro, albeit at a much lower rate 
(Fig. 22). (Whereas the degradation rate of ClpC-WB1 is slower than that of ClpC-WB2). 
This indicated that both ATP binding sites are necessary for a full ATPase induction of the 
ClpC hexamer by MecA and it also strongly suggests that a synergistic cooperation, between 
the ATPase of two AAA+ domains must exist (Turgay et al., 2001).  
A coordinated ATP hydrolysis within the ClpC hexamer seem
a
o
T
v
re
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2001) of the respective clpC-WB1 and clpC-WB2 strains displayed only partial phenotypes. 
he heat resistance of clpC-WB2 was partially more affected then clpC-WB1 as observed 
ClpC-WB2 could form MecA dependent higher oligomers 
omparable to ClpC-DWB (compare Fig. 23B and 24B). 
he importance of the first AAA+ domain of ClpC for a stable MecA interaction in 
 MecA are located in or next to 
AA-1. 
 mediate MecA association 
r of ClpC (CNTD-ClpA 
 
the single domain variants of ClpC, resulting from the deletion of the N-domain or the Linker 
domain (ClpC-∆Li and ClpC-∆NTD), is one order of magnitude lower (T.S., D. Dougan, J. 
Kirstein, A.Mogk, B.Bukau & K.Turgay in preparation). 
T
previously for other mutants in the first and second AAA+ domain of ClpC,(Turgay et al., 
2001), but clpC-DWB was unable to grow under these conditions (Fig32). 
However this work demonstrates that MecA could stably interact with ClpC, when the first 
AAA+ domain was altered in such a way that it could bind but not hydrolyze ATP (ClpC-
WB1) (Fig. 23). A similar mutation in the second AAA+ domain (ClpC-WB2) showed no 
stabilization by MecA in gelfiltration experiments. Only GA crosslink experiments 
demonstrated that ClpC-WB1 and 
c
T
gelfiltration runs suggested that the binding partner(s) for
A
 
 
5.2.4 N-domain and Linker
 
The ClpC domains located in AAA-1 necessary and sufficient for the heterodimer formation 
are the N-domain and the linker domain. The N-domain interacts stronger with MecA 
compared to the Linker domain of ClpC. Since the presence of one of the two domains is not 
sufficient for the heterodimer formation a concurrent interaction of MecA with both domains 
is likely to occur.  
The absence of one of the two domains in ClpC, which can interact on their own with MecA, 
has a negative effect on the binding ability of these ClpC-deletion variants to MecA. This 
negative cooperative effect suggests that for ClpC the presence of both domains, possibly 
interacting with one another, is necessary to allow a productive interaction with MecA.  
To test the importance of the N-domain and the Linker D. Dougan and J. Kirstein constructed 
hybrid proteins of ClpA combined with the N-domain and the Linke
and ClpA-CLi) and analyzed the MecA interaction of these proteins with surface plasmon 
resonance. Both hybrid proteins showed MecA interaction proving that these ClpC domains 
are responsible for MecA interaction. Compared to the interaction of the single domain ClpA
hybrid proteins or the single N-domain of ClpC the strength of the interaction with MecA of 
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The interaction of MecA with the NTD of ClpC could be important for the delivery of the 
substrate, preparing ClpC to accept substrate protein, as discussed e.g. for ClpS and the NTD 
of ClpA (Zeth et al., 2002b). Other N-domain’s of HSP100/Clp proteins, not homologous to 
the N-domain of ClpC, were also identified as interacting partners for adaptor proteins like 
on the analysis of the three obtained 
or M3 and M4 in (Lee et al., 2003)). The investigation of a structural model of ClpC 
uilt upon the ClpB structure, which took the shortened Linker domain of ClpC into account, 
emonstrated that the NTD of ClpC could be positioned proximal to the linker domain (data 
obile ClpC Linker domain and the N-
rminal domain would be feasible and would position the flexible NTD in a position which 
s hypothesis no higher oligomer form of ClpC was detected for ClpC-∆Li, 
∆Li (Fig. 30, data not shown).  
In vivo clpC-∆Li displayed a defect comparable to a clpC knock out, because competence 
measured by β-Galactosidase activity also indicated that no ClpC-∆Li- MecA interaction is 
 
 
The results presented in this work lead to the following model of ClpC oligomerisation 
mediated by MecA or other adaptor proteins (Fig 38). 
e.g. SspB and the N-domain of ClpX (Dougan et al., 2002c; Dougan et al., 2003; Wojtyra et 
al., 2003; Zeth et al., 2002b) or the N-domain of p97, which is also the interacting site for p97 
specific adaptor proteins (Yuan et al., 2001). The structure of ClpB from Thermus 
thermophilus has recently been determined. The Linker domain of ClpB comprises an 
independently folded mobile domain consisting of two coiled coil structures, whose mobility 
is important for the chaperone function of ClpB. In additi
structures demonstrated that the N-domain is very mobile (Lee et al., 2003). Analyzing the 
homologous linker domain from ClpC revealed that it lacks the second coiled coil structure 
(Motif 2 
b
d
not shown). A concurrent contact of MecA with the m
te
may allow better access of the substrate to the pore of the hexameric ClpC.  
The interaction of different adaptor proteins with the NTD’s of ClpA or ClpX was shown to 
be necessary for the targeting activity of this adaptor. The additional interaction of MecA with 
the linker could therefore be necessary for the assistance of oligomerisation of ClpC. 
Consistent with thi
with or without MecA in the GA crosslink experiment, even at higher concentrations of ClpC-
possible (Fig. 36). 
5.2.5 Model of MecA mediated oligomerisation 
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MecA binds independently of ATP to the N-terminal domain and the Linker of ClpC; a 
heterodimer between these two proteins is formed, stable enough to be detected by 
gelfiltration experiments, if the walker B motif of the AAA-1 domain is mutated in a way that 
ATP hydrolysis is not possible. In presence of ATP and MecA conformational changes of 
ClpC are likely to occur which enables the formation of a stable oligomere o
Figure 38 A model summarising the mechanism of the activation by oligomerisation of the AAA+ protein  
 
f ClpC with up to 
spF is a bacterial enhancer protein of the AAA+ family, which, as a 
examer, activates σ54 dependent transcription (Chaney et al., 2001; Zhang et al., 2002). 
spA is an inhibitor of PspF and because it inhibits the ATPase activity of PspF, it has been 
oligomer formation of this AAA+ protein 
workin et al., 2000; Elderkin et al., 2002) 
 katanin is a heterodimer consisting of 
p60, containing a single AAA+ domain and p80 whose WD40 domain allows targeting of the 
six MecA molecules bound. This complex is able to interact with substrates like α-casein and 
fulfill the chaperone activities as described for the ClpC/MecA system, or to degrade substrate 
proteins in connection with the peptidase subunit ClpP. 
 
5.2.6 Oligomerisation of other AAA+ proteins 
 
For at least one other member of the AAA+ protein family, it has been suggested but not 
demonstrated, that an adaptor protein negatively regulated its activity by controlling its 
oligomeric state. P
h
P
suggested that it could act by inhibiting the 
(D
A dynamic oligomerisation of an AAA+ protein has also been observed for other AAA+ 
proteins. The specialized microtubule severing ATPase
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complex to the centrosome of eukaryotic cells (Hartman et al., 1998; McNally and Vale, 
1993). Experiments with the isolated p60 demonstrated, that a hexamer of p60 could only be 
detected in a stable manner, when the Walker B motif was altered, as described above for 
ClpC. This oligomeric p60 could interact via its N-terminus with multimers of tubulin but not 
with tubulin monomers and the ATPase induction of p60 by tubulin correlated with its 
oligomer formation and tubulin severing activity (Hartman and Vale, 1999). The p80 subunit, 
which possesses no ATPase activity, can also induce the ATPase and the tubulin induced 
ATPase of p60 at least twofold (Hartman et al., 1998). The influence of p80 on the 
oligomerisation of p60 was not examined in these experiments. It would be tempting to 
speculate that, because of its p60 ATPase induction activity, p80 might also assist the 
oligomerisation of p60. 
 
 
f ClpC in a wide variety of different 
spects of the B. subtilis cellular physiology, by presenting specific substrates like ComK. 
sation is a concept, which also applies to the 
nderstanding of the function and regulation of seemingly distant AAA+ proteins of 
 
5.3 Conclusions 
 
The results for ClpC and MecA demonstrate that controlling the ability of an AAA+ protein 
to form an active hexameric ring is an important functional aspect and a mechanism by which 
the recognition and targeting of misfolded/aggregated proteins or specific proteins like ComK 
to ClpC can be regulated. The adaptor protein MecA activates the ATPase activity and 
coordinates substrate availability with the activation of ClpC, adding a new layer of regulation 
of HSP100/Clp proteins and enabling the involvement o
a
This notion of controllable dynamic oligomeri
u
eukaryotic origin, involved in various and diverse fundamental cellular functions. 
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